TW201132745A - Liquid crystal aligning agent and liquid crystal display element using same - Google Patents
Liquid crystal aligning agent and liquid crystal display element using same Download PDFInfo
- Publication number
- TW201132745A TW201132745A TW99143744A TW99143744A TW201132745A TW 201132745 A TW201132745 A TW 201132745A TW 99143744 A TW99143744 A TW 99143744A TW 99143744 A TW99143744 A TW 99143744A TW 201132745 A TW201132745 A TW 201132745A
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- formula
- crystal alignment
- diamine
- treatment agent
- Prior art date
Links
- 0 CC(C1)C(OCc2cc(N)cc(N)c2)=CC=C1C1CCC(*)CC1 Chemical compound CC(C1)C(OCc2cc(N)cc(N)c2)=CC=C1C1CCC(*)CC1 0.000 description 2
- XIWMTQIUUWJNRP-UHFFFAOYSA-N Nc(cc1N)ccc1O Chemical compound Nc(cc1N)ccc1O XIWMTQIUUWJNRP-UHFFFAOYSA-N 0.000 description 1
- OANNLQHCTUZSCI-UHFFFAOYSA-N Nc1cc(COc(cc2)ccc2-c(cc2)ccc2O)cc(N)c1 Chemical compound Nc1cc(COc(cc2)ccc2-c(cc2)ccc2O)cc(N)c1 OANNLQHCTUZSCI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
- C08L79/04—Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
- C08L79/08—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1075—Partially aromatic polyimides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1085—Polyimides with diamino moieties or tetracarboxylic segments containing heterocyclic moieties
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Physics & Mathematics (AREA)
- Nonlinear Science (AREA)
- Liquid Crystal (AREA)
- General Physics & Mathematics (AREA)
- Mathematical Physics (AREA)
- Optics & Photonics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
201132745 六、發明說明: 【發明所屬之技術領域】 本發明係關於一種液晶顯示元件用之液晶配向處理劑 、液晶配向膜、及液晶顯示元件者。 【先前技術】 目前’液晶顯示元件之液晶配向膜主要係使用塗佈以 聚醯胺酸等之聚醯亞胺前驅物或可溶性聚醯亞胺之溶液作 爲主成分之液晶配向處理劑並經燒成,接著施以摩擦處理 之所謂聚醯亞胺系之液晶配向膜。 液晶配向膜不僅可控制液晶之配向狀態亦影響液晶顯 示元件之特性。尤其,摩擦處理時之膜剝離,削減之問題 ,及抑制隨著液晶顯示元件之高精密化的液晶顯示元件之 對比性下降或殘像現象之減低之特性變得重要。 聚醯亞胺系之液晶配向膜中,作爲縮短因直流電壓而 發生之殘像消失前的時間者,已知有使用除了聚醯胺酸或 含有醯亞胺基之聚醯胺酸以外還含有特定構造之三級胺之 液晶配向處理劑者(參照例如專利文獻1 ),及使用含有 使用具有吡啶骨架等特定二胺作爲原料之可溶性聚醯亞胺 之液晶配向處理劑者(參照例如專利文獻2 )等, 另外,聚醯亞胺系之液晶配向膜中,作爲使電壓維持 率增高,且縮短因直流電壓產生之殘像消失前之時間者, 除聚醯胺酸或其醯亞胺化聚合物等以外,已知亦使用含有 極少量之由分子內含有一個羧酸基之化合物'分子內含有 201132745 一個羧酸酐基之化合物及分子內含有一個三級胺基之化合 物所選出之化合物之液晶配向處理劑者(參照例如專利文 獻3 )。 [先前技術文獻] 專利文獻 專利文獻1 :特開平9_3 1 62 00號公報 專利文獻2:特開平1 0- 1 0463 3號公報 專利文獻3 :特開平8-76 1 2 8號公報 【發明內容】 [發明欲解決之課題] 本發明係鑑於上述狀況而完成者,其目的係提供一種 可獲得在摩擦時之膜剝離或削減較強,電壓維持率高,且 即使施加直流電壓亦難以引起初期電荷累積之液晶配向膜 之液晶配向處理劑。 [解決課題之手段] 本發明人進行積極硏究之結果,發現含有使用含有新 穎化合物之特定二胺化合物作爲二胺成分之聚醯胺酸,及 /或使該聚醯胺酸進行醯亞胺化獲得之聚醯亞胺之液晶配 向處理劑在達成上述目的方面極爲有效,因而完成本發明 。亦即,本發明爲具有以下要旨者》 (1 ) 一種液晶配向處理劑,該處理劑含有由使包含 -6- 201132745 以下述式π]表示之二胺化合物之二胺成分與四殘酸二酉干 成分反應獲得之聚醯胺酸,及使該聚醯胺酸進行醯亞胺化 獲得之聚醯亞胺所組成群組所選出之至少一種聚合物, ^-Ar[Technical Field] The present invention relates to a liquid crystal alignment treatment agent for a liquid crystal display element, a liquid crystal alignment film, and a liquid crystal display element. [Prior Art] At present, the liquid crystal alignment film of the liquid crystal display element mainly uses a liquid crystal alignment treatment agent which is coated with a solution of a polyamidene precursor such as polyacrylamide or a soluble polyimine, and is burned. Then, a so-called polyimine-based liquid crystal alignment film which is subjected to rubbing treatment is applied. The liquid crystal alignment film not only controls the alignment state of the liquid crystal but also affects the characteristics of the liquid crystal display element. In particular, the problem of film peeling during the rubbing treatment, the problem of reduction, and the suppression of the decrease in the contrast of the liquid crystal display element with the high precision of the liquid crystal display element or the reduction of the afterimage phenomenon become important. In the polyimine-based liquid crystal alignment film, it is known to use a polyamic acid other than polyacrylic acid or a ruthenium-based group, in addition to reducing the time before the afterimage disappears due to a DC voltage. A liquid crystal alignment treatment agent of a tertiary amine having a specific structure (see, for example, Patent Document 1), and a liquid crystal alignment treatment agent containing a soluble polyimine having a specific diamine such as a pyridine skeleton as a raw material (refer to, for example, the patent document) 2) In addition, in the polyimine-based liquid crystal alignment film, as long as the voltage maintenance ratio is increased and the time before the afterimage due to the DC voltage is shortened, the polyamine or its hydrazine imidization is removed. In addition to polymers and the like, it is also known to use a compound selected from a compound containing a carboxylic acid group in a molecule and a compound having a carboxylic anhydride group of 201132745 and a compound having a tertiary amino group in the molecule. The liquid crystal alignment treatment agent (see, for example, Patent Document 3). [PRIOR ART DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT PATENT DOCUMENT [Problem to be Solved by the Invention] The present invention has been made in view of the above circumstances, and an object thereof is to provide a film which can be peeled off or reduced in friction and has a high voltage holding ratio, and it is difficult to cause an initial stage even if a DC voltage is applied. A liquid crystal alignment treatment agent for a liquid crystal alignment film of charge accumulation. [Means for Solving the Problem] As a result of active research, the present inventors have found that polyamines containing a specific diamine compound containing a novel compound as a diamine component are contained, and/or the polyamic acid is subjected to ruthenium imine. The liquid crystal alignment treatment agent of the obtained polyimine is extremely effective in achieving the above object, and thus the present invention has been completed. That is, the present invention has the following object: (1) A liquid crystal alignment treatment agent containing a diamine component and a tetraresin acid of a diamine compound represented by the following formula π]: -6-201132745 At least one polymer selected from the group consisting of a polylysine obtained by reacting a dry component and a polyimine obtained by subjecting the polyamic acid to ruthenium imidization, ^-Ar
(式中’ Ar表示碳環芳香族化合物或含有氮原子之雜環芳 香族化合物,且構成環之碳原子或氮原子上之氫原子可經 取代)。 (2 )如上述(1 )所述之液晶配向處理劑,其中式 [1]之Ar爲六員環之碳環芳香族化合物或六員環之含氮原 子之雜環芳香族化合物。 (3 )如上述(1 )所述之液晶配向處理劑,其中式 [1]之Ar爲五員環之含氮原子之雜環芳香族化合物。 (4 )如上述(1 )所述之液晶配向處理劑,其中式 [1 ]之Ar爲苯、吡啶、嗒嗪、嘧啶、吡嗪或三嗪。 (5 )如上述(1 )所述之液晶配向處理劑,其中式 [i ]之A r爲嚼唑、噁二唑、噻唑、噻二唑、吡咯、咪唑、 吡唑或三唑。 (6 )如上述(1 )所述之液晶配向處理劑,其中以式 [1]表示之二胺化合物爲以下述通式[4]至式[6]表示之任一 種化合物(Α Γ係與上述同義)’ 201132745 [化2](wherein 'Ar' represents a carbocyclic aromatic compound or a heterocyclic aromatic compound containing a nitrogen atom, and a hydrogen atom constituting a ring or a hydrogen atom of a nitrogen atom may be substituted). (2) The liquid crystal alignment treatment agent according to the above (1), wherein Ar of the formula [1] is a carbocyclic aromatic compound of a six-membered ring or a heterocyclic aromatic compound of a nitrogen-containing atom of a six-membered ring. (3) The liquid crystal alignment treatment agent according to the above (1), wherein Ar of the formula [1] is a heterocyclic aromatic compound containing a nitrogen atom of a five-membered ring. (4) The liquid crystal alignment treatment agent according to the above (1), wherein Ar of the formula [1] is benzene, pyridine, pyridazine, pyrimidine, pyrazine or triazine. (5) The liquid crystal alignment treatment agent according to the above (1), wherein A r of the formula [i] is a azole, an oxadiazole, a thiazole, a thiadiazole, a pyrrole, an imidazole, a pyrazole or a triazole. (6) The liquid crystal alignment treatment agent according to the above (1), wherein the diamine compound represented by the formula [1] is a compound represented by the following general formula [4] to formula [6] (anthraquinone and The above synonymous)' 201132745 [Chemical 2]
(7 )如 μ、、 t遮(1 )所述之液晶配向處理劑,其中以式 [1 ]表示之二胳^ &化合物爲以下述通式[2]表示之化合物(Ar 係與上述同義).(7) The liquid crystal alignment treatment agent according to the formula (1), wherein the compound represented by the formula [1] is a compound represented by the following formula [2] (Ar system and the above Synonymous).
H2NH2N
[化3] (8 )如上述(〗)〜(7 )中任—項所述之液晶配向處 理劑’其中至少含有1〇莫耳%以上之以下述式[3]表示之二 胺化合物作爲二胺成分: H2N-A r ' ~Ri_Nh-R2 [3] (式中’ Ar’表示伸苯基或伸萘基,1表示碳數1〜5之伸烷 基’R2表示碳數1〜5之烷基)。 (9 )如上述(1 )〜(8 )中任一項所述之液晶配向處 理劑,其中四羧酸二酐成分包含具有脂環式構造或脂肪族 構造之四羧酸二酐。 (1 0 ) —種液晶配向膜,其爲將上述(1 )〜(9 )中 任一項所述之液晶配向處理劑塗佈於附電極之基板上,並 燒成而成。 -8 - 201132745 (11) 一種液晶顯不兀件’其具備上述(10)所述之 液晶配向膜。 (12) —種以下述式[1]表示之二胺化合物, ^Ar(8) The liquid crystal alignment agent according to any one of the above-mentioned items, wherein the diamine compound represented by the following formula [3] is contained at least 1 mol% or more Diamine component: H2N-A r ' ~Ri_Nh-R2 [3] (wherein Ar' represents a phenyl or anthracene group, and 1 represents an alkylene group having a carbon number of 1 to 5 'R2 represents a carbon number of 1 to 5 Alkyl). The liquid crystal alignment treatment agent according to any one of the above aspects, wherein the tetracarboxylic dianhydride component comprises a tetracarboxylic dianhydride having an alicyclic structure or an aliphatic structure. (10) A liquid crystal alignment film obtained by applying the liquid crystal alignment treatment agent according to any one of the above (1) to (9) to a substrate to which an electrode is attached, and firing the substrate. -8 - 201132745 (11) A liquid crystal display member comprising the liquid crystal alignment film according to (10) above. (12) A diamine compound represented by the following formula [1], ^Ar
[化 4] 〇 (式中,Ar表示碳環芳香族化合物或含有氮原子之雜環芳 香族化合物,且構成環之碳原子上或氮原子上之氫原子可 經取代)。 (13) 如上述(12)所述之二胺化合物,其中式π] 之Ar爲六員環之碳環芳香族化合物或六員環之含氮原子之 雜環芳香族化合物。 (14) 如上述(12)所述之二胺化合物,其中式[j] 之Ar爲五員環之含氮原子之雜環芳香族化合物。 (1 5 )如上述(1 2 )所述之二胺化合物,其中式[i ] 之Ar爲苯、吡啶、嗒嗪、嘧啶、吡嗪或三嗪。 (16)如上述(12)所述之二胺化合物,其中式 之Ar爲噁唑、噁二唑、噻唑、噻二唑、吡咯、咪唑、吡唑 或三唑。 (1 7 )如上述(1 2 )所述之二胺化合物,其中以式 [1]表示之二胺化合物爲以下述通式[4]至式[6]表示之任一 種化合物, 201132745 [化5](In the formula, Ar represents a carbocyclic aromatic compound or a heterocyclic aromatic compound containing a nitrogen atom, and a hydrogen atom constituting a carbon atom of a ring or a nitrogen atom may be substituted). (13) The diamine compound according to the above (12), wherein Ar of the formula π] is a carbocyclic aromatic compound of a six-membered ring or a heterocyclic aromatic compound containing a nitrogen atom of a six-membered ring. (14) The diamine compound according to the above (12), wherein Ar of the formula [j] is a heterocyclic aromatic compound having a nitrogen atom of a five-membered ring. (1) The diamine compound according to (1) above, wherein Ar of the formula [i] is benzene, pyridine, pyridazine, pyrimidine, pyrazine or triazine. (16) A diamine compound according to the above (12), wherein Ar is an oxazole, an oxadiazole, a thiazole, a thiadiazole, a pyrrole, an imidazole, a pyrazole or a triazole. (1) The diamine compound of the above formula (1), wherein the diamine compound represented by the formula [1] is a compound represented by the following formula [4] to formula [6], 201132745 [Chemical 5]
[4][4]
H2NH2N
Ar NH2 (1 8 )如上 [1 ]表示之二胺化 [化6] 述(1 2 )所述之二胺化合物,其中以式 合物爲以下述通式[2]表示之化合物:The arsenic compound of the above formula (1 2), wherein the compound is a compound represented by the following formula [2]:
H2NH2N
(19) ''種聚醯胺酸或聚醯亞胺,其爲使包含上述( 1 2 )〜(1 8 )中任—項所述之二胺化合物之二胺成分與四 竣酸一酌1成分反應獲得之聚醯胺酸,或使該聚醯胺酸進行 醯亞胺化而獲得之聚醯亞胺^ [發明效果] $發明之液晶配向處理劑可獲得在摩擦時之膜剝離或 削減較強’電壓維持率高,且即使對液晶胞施加直流電壓 亦難以引起初期電荷累積之液晶配向膜,且藉由使用液晶 配向膜可製作特性良好之液晶面板。 另外,依據本發明,提供一種可使用作爲液晶配向處 理劑的聚醯胺酸及聚醯亞胺之原料等之新穎二胺化合物。 【實施方式】 -10- 201132745 本發明之液晶配性處理劑爲含有使含有以下述式[1 ] 表示之特定二胺化合物之二胺成分與四羧酸二酐成分反應 獲得之聚醯胺酸,及使該聚醯胺酸進行醢亞胺化而成之聚 醯胺之內之至少一種聚合物之液晶配性處理劑。該特定之 二胺化合物包含文獻未記載之新穎化合物,藉由使用該特 定之二胺化合物,即使液晶配向處理中爲必要之摩擦處理 ’亦可減輕摩擦時之膜剝離或削減,所得液晶配向膜之電 壓維持率高,亦即,即使對液晶胞施加直流電壓亦難以造 成初期電荷之累積。 〈式[1 ]之二胺化合物〉 上述式[1]中,Ar表示碳環芳香族化合物、或含有氮 原子之雜環芳香族化合物,該Ar由於成爲與電荷之授受有 關之部位,故較好爲電性上活性之構造,其中,以含有氮 原子之雜環芳香族化合物較佳。(19) ''Polymeric acid or polyimine, which is a diamine component and tetradecanoic acid containing the diamine compound according to any one of the above (1 2) to (1 8) a polyaminic acid obtained by the reaction of the component 1 or a polyimine obtained by subjecting the polyamic acid to ruthenium imidation. [Inventive effect] The liquid crystal alignment treatment agent of the invention can obtain film peeling during rubbing or A liquid crystal alignment film having a high voltage holding ratio and having a high DC voltage is hard to cause initial charge accumulation even when a DC voltage is applied to the liquid crystal cell, and a liquid crystal panel having excellent characteristics can be produced by using a liquid crystal alignment film. Further, according to the present invention, there is provided a novel diamine compound which can be used as a raw material of polyamic acid and polyimine which is a liquid crystal alignment agent. [Embodiment] -10-201132745 The liquid crystal compounding agent of the present invention is a polyamic acid obtained by reacting a diamine component containing a specific diamine compound represented by the following formula [1] with a tetracarboxylic dianhydride component. And a liquid crystal compounding agent for at least one polymer of the polyamine which is obtained by hydrazine imidation of the polyamic acid. The specific diamine compound contains a novel compound not described in the literature, and by using the specific diamine compound, even if the rubbing treatment is necessary in the liquid crystal alignment treatment, the film peeling or reduction at the time of rubbing can be reduced, and the obtained liquid crystal alignment film can be obtained. The voltage holding ratio is high, that is, even if a DC voltage is applied to the liquid crystal cell, it is difficult to cause accumulation of initial charges. <Diamine compound of the formula [1]> In the above formula [1], Ar represents a carbocyclic aromatic compound or a heterocyclic aromatic compound containing a nitrogen atom, and since this Ar is a site related to the charge and reception, It is preferably an electrically active structure in which a heterocyclic aromatic compound containing a nitrogen atom is preferred.
Ar只要是碳環芳香族化合物或含有氮原子之雜環芳香 族化合物即無特別限制’但由於若導入體積大之構造或分 子量大之環時有使液晶配向性混亂之可能性,故宜爲分子 量較低者。 再者’ Ar由於構成一價之基,故本說明書中,如上述 ’就方便起見’記載爲碳環芳香族化合物或含有氮原子之 雜環芳香族化合物等’但Ar由於構成一價之基,故若嚴謹 表現時’於碳環芳香族化合物時,意指自碳環芳香族化合 物去除一個氫原子之殘基’又’於含氮原子之雜環芳香族 -11 - 201132745 化合物時,意指自含氮原子之雜環芳香族化合物去除一個 氫原子之殘基。Ar爲苯、吡啶、嗒嗪、嘧啶、吡嗪、三嗪 、噁唑、噁二唑、噻唑、噻二唑、吡咯、咪唑、吡唑或三 唑之情況亦相同,意指自該等化合物去除一個氫原子之各 殘基。 上述式[1]中之Ar之碳環芳香族化合物或含氮原子之 雜環芳香族化合物之環之形態並無特別限制,爲五員環、 六員環均可獲得良好之特性。 五員環之碳環芳香族化合物或含氮原子之雜環芳香族 化合物已知相較於六員環之該等其環本身之反應性較高。 因此,在液晶配向膜之形成時所進行之高溫下之燒成過程 中會使環反應而引起交聯,故就摩擦耐性之觀點而言係較 佳。另一方面,就液晶配向膜之電特性方面而言,以構造 安定性高之六員環之碳環芳香族化合物或含氮原子之雜環 芳香族化合物較佳。 另外,式[1 ]中之Ar可係如聯苯、聯吡啶之使相同環 連結而成,亦可係如苯基吡啶或苯基噻吩之使不同種類之 環彼此連結而成。又亦可成爲如喹啉或苯并咪唑之縮環構 造。 上述碳環芳香族化合物之具體例列舉爲環戊二烯、苯 、葜、萘、蒽、菲、嵌二萘(pyrene )、并四苯( Naphthacene)、苯并嵌二萘、菲(perylene)、五聯苯( pentacene )、迫苯并萘(Phenalene )、茚、蕗、聯苯等 -12- 201132745 又,上述含氮原子之雜環芳香族化合物之具體例列舉 爲吡咯、吡啶、嗒嗪、嘧啶、吡嗪、三嗪、四嗪、咪唑、 吡唑、噁唑、異噁唑、噁二唑、噻唑、異噻唑、噻二唑、 三唑、四唑、吲哚、吲唑、苯并咪唑、苯并噁唑、苯并異 噁唑、苯并噻唑、苯并異噻唑、唾咐、異喹啉、噌啉、酞 曝 (Phthalazine)、嗤哩啉、嗤嚼啉、萘陡 ( Naphthyridine)、喋卩定(Pteridine)、嘌哈、香豆素、異 香豆素、味哩、定、菲繞琳(Phenanthroline)、噻吩 并卩比 D定(thienopyridine) ' 咲喃并 D比陡(Furopyridines) 、D引 B朵曉(indolizine)、喹啉 D定、咔琳(carbolin)等。 又,吡咯、吡唑、咪唑等中之N - Η部位可爲就此或亦可經 甲基化等之烷化。Ar is not particularly limited as long as it is a carbocyclic aromatic compound or a heterocyclic aromatic compound containing a nitrogen atom. However, when a structure having a large volume or a ring having a large molecular weight is introduced, there is a possibility that liquid crystal alignment property is disturbed. The lower molecular weight. In addition, since Ar is a base of valence, in the present specification, as described above, it is described as a carbocyclic aromatic compound or a heterocyclic aromatic compound containing a nitrogen atom, etc. 'But Ar constitutes a monovalent value. a base, so if it is strictly expressed in the case of a carbocyclic aromatic compound, it means that a residue of a hydrogen atom is removed from a carbocyclic aromatic compound, and when it is a compound containing a nitrogen atom, a heterocyclic aromatic-11 - 201132745 compound It means the removal of a residue of a hydrogen atom from a heterocyclic aromatic compound containing a nitrogen atom. Ar is also the same as benzene, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazole, oxadiazole, thiazole, thiadiazole, pyrrole, imidazole, pyrazole or triazole, meaning from such compounds Remove each residue of a hydrogen atom. The form of the ring of the carbocyclic aromatic compound of Ar or the heterocyclic aromatic compound containing a nitrogen atom in the above formula [1] is not particularly limited, and good properties can be obtained for the five-membered ring and the six-membered ring. The carbon ring aromatic compound of the five-membered ring or the heterocyclic aromatic compound containing a nitrogen atom is known to have higher reactivity than the ring itself of the six-membered ring. Therefore, in the firing process at a high temperature which is performed at the time of formation of the liquid crystal alignment film, the ring reacts to cause crosslinking, which is preferable from the viewpoint of friction resistance. On the other hand, in terms of electrical characteristics of the liquid crystal alignment film, a carbon ring aromatic compound having a six-membered ring having a high stability or a heterocyclic aromatic compound containing a nitrogen atom is preferred. Further, Ar in the formula [1] may be obtained by linking the same ring such as biphenyl or bipyridine, or may be formed by linking different kinds of rings such as phenylpyridine or phenylthiophene. It may also be a condensed ring structure such as quinoline or benzimidazole. Specific examples of the above carbocyclic aromatic compound are cyclopentadiene, benzene, anthracene, naphthalene, anthracene, phenanthrene, pyrene, naphthacene, benzoxylene, and perylene. , pentacene, Phenalene, hydrazine, hydrazine, biphenyl, etc. -12- 201132745 Further, specific examples of the above heterocyclic aromatic compound containing a nitrogen atom are exemplified as pyrrole, pyridine, pyridazine , pyrimidine, pyrazine, triazine, tetrazine, imidazole, pyrazole, oxazole, isoxazole, oxadiazole, thiazole, isothiazole, thiadiazole, triazole, tetrazole, hydrazine, carbazole, benzene Imidazole, benzoxazole, benzisoxazole, benzothiazole, benzisothiazole, salivary, isoquinoline, porphyrin, Phthalazine, porphyrin, hydrazine, naphthalene Naphthyridine), Pteridine, hip hop, coumarin, isocoumarin, miso, Phenanthroline, thienopyridine, 咲 并 and D ratio steep ( Furopyridines), D introduces indolizine, quinoline D, and carbolin. Further, the N - oxime moiety in the pyrrole, pyrazole, imidazole or the like may be alkylated as such or may be methylated or the like.
Ar之較佳具體例列舉爲環戊二烯、苯、葜、萘、茚、 苐、聯苯、吡咯、吡啶、嗒嗪、嘧啶、吡嗪 '三嗪、四嗪 、咪唑、吡唑、噁唑、異噁唑、噁二唑、噻唑、異噻唑、 噻二唑、三唑、四唑、吲哚、吲唑、苯并咪唑、苯并噁唑 '苯并異噁唑、苯并噻唑、苯并異噻唑、喹啉、異喹啉、 噌啉、酞嗪、喹唑啉、嗤噁啉、萘啶、喋啶、嘌呤、香豆 素、異香豆素、咔唑、噻吩并吡啶、呋喃并吡啶、吲哚曉 、嗤啉啶、咔啉。最好爲苯、吡啶、嗒嗪、嘧啶、吡嗓、 三嗪、吡略、噁唑、噁二唑、噻唑、噻二唑、咪唑、啦哩 或三唑。 構成上述碳環芳香族化合物或含氮原子之雜環芳香族 化合物中之環之碳原子或氮原子上之氫原子亦可經取代。 -13- 201132745 取代基之種類及數目並無特別限制,但甲基、乙基、烷氧 基、甲氧基、乙氧基、胺基、二甲胺基等分子量較小之電 子給予性取代基,或羧基、硝基、氰基等分子量較小之拉 電子性取代基使電子之授受活性化故而較佳。與碳環芳香 族化合物或雜環芳香族化合物之取代基位置並無特別限制 ’但含氮雜環芳香族化合物時,取代基之位置較好爲不與 氮原子鄰接之位置。 另一方面,就成爲液晶配向膜時之液晶配向性或摩擦 耐性’或合成難易等之觀點而言,較好爲未經取代或以甲 基或乙基等較小之取代基取代之碳環芳香族化合物或含氮 原子之雜環芳香族化合物。 以通式[1]表示之二胺中,苯環上之各取代基之位置 並無特別限制。就成爲液晶配向膜時之液晶配向性之觀點 而言,兩個胺基之位置關係較好爲間位或對位,又就提高 聚醯胺酸或聚醯亞胺之溶劑溶解性之觀點而言,更好爲間 位。兩個胺基之位置關係爲間位時,亦即1,3 -二胺基苯構 造時,伸甲基酯之位置較好爲4或5之位置,尤其就提高月安 基之親核性之效果或可容易合成之觀點而言,最好爲5之 位置。 以通式[1]表示之二胺之較佳具體例列舉爲下述式[2] 、式[4]、式[5]或式[6]之化合物。 -14 - 201132745 [化7]Preferred specific examples of Ar are exemplified by cyclopentadiene, benzene, anthracene, naphthalene, anthracene, anthracene, biphenyl, pyrrole, pyridine, pyridazine, pyrimidine, pyrazine 'triazine, tetrazine, imidazole, pyrazole, and evil. Azole, isoxazole, oxadiazole, thiazole, isothiazole, thiadiazole, triazole, tetrazole, guanidine, oxazole, benzimidazole, benzoxazole 'benzisoxazole, benzothiazole, Benzoisothiazole, quinoline, isoquinoline, porphyrin, pyridazine, quinazoline, anthraquinone, naphthyridine, acridine, hydrazine, coumarin, isocoumarin, carbazole, thienopyridine, furan And pyridine, xiaoxiao, porphyrin pyridine, porphyrin. Most preferred are benzene, pyridine, pyridazine, pyrimidine, pyridinium, triazine, pyroline, oxazole, oxadiazole, thiazole, thiadiazole, imidazole, oxime or triazole. The carbon atom or the hydrogen atom on the nitrogen ring constituting the above-mentioned carbocyclic aromatic compound or heterocyclic aromatic compound containing a nitrogen atom may also be substituted. -13- 201132745 There are no particular restrictions on the type and number of substituents, but electron-donating substitutions such as methyl, ethyl, alkoxy, methoxy, ethoxy, amine, and dimethylamino groups are relatively small. The electron-donating substituent having a small molecular weight such as a carboxyl group, a nitro group or a cyano group is preferred because it permits the activation of electrons. The position of the substituent with the carbocyclic aromatic compound or the heterocyclic aromatic compound is not particularly limited. However, in the case of the nitrogen-containing heterocyclic aromatic compound, the position of the substituent is preferably a position not adjacent to the nitrogen atom. On the other hand, from the viewpoint of liquid crystal alignment property or friction resistance when liquid crystal alignment film is formed, or difficulty in synthesis, etc., it is preferably a carbon ring which is unsubstituted or substituted with a smaller substituent such as a methyl group or an ethyl group. An aromatic compound or a heterocyclic aromatic compound containing a nitrogen atom. In the diamine represented by the formula [1], the position of each substituent on the benzene ring is not particularly limited. From the viewpoint of liquid crystal alignment in the case of a liquid crystal alignment film, the positional relationship between the two amine groups is preferably a meta or para position, and the viewpoint of improving the solvent solubility of polyperuric acid or polyimine. Words are better for the position. When the positional relationship between the two amine groups is meta, that is, when the 1,3 -diaminobenzene structure is constructed, the position of the methyl ester is preferably 4 or 5, especially to improve the nucleophilicity of the acetaminophen. The effect is preferably 5 in terms of the effect or the ease of synthesis. A preferred specific example of the diamine represented by the general formula [1] is a compound of the following formula [2], formula [4], formula [5] or formula [6]. -14 - 201132745 [Chem. 7]
再者,式中’ A r較好爲苯、吡啶、嗒嗪、嘧啶、吡嗪 、三嗪、吡咯 '噁唑、噁二唑、噻唑、噻二唑、咪唑 '吡 唑或三唑。 〈式[1]之二胺化合物之合成〉 以通式[1 ]表示之二胺之合成法並無特別限制,例如 可合成以下述通式[7]表示之二硝基化合物,進而以通常 方法使硝基還原轉換成胺基之方法而合成。 [化 8] ηFurther, in the formula, 'A r is preferably benzene, pyridine, pyridazine, pyrimidine, pyrazine, triazine, pyrrole 'oxazole, oxadiazole, thiazole, thiadiazole, imidazole 'pyrazole or triazole. <Synthesis of the diamine compound of the formula [1]> The synthesis method of the diamine represented by the general formula [1] is not particularly limited, and for example, a dinitro compound represented by the following formula [7] can be synthesized, and The method synthesizes a method in which a nitro group is converted into an amine group. [化8] η
以上述通式[7]表示之二硝基化合物,係如下述,可 藉由對應之二硝基苄基醇之酯化合成。亦即,藉由使二硝 基苄基醇與羧醯氯或酸二酐在吡啶或三乙胺等鹼存在下反 應而合成。又,Ar係對應於成爲目的之上述通式[丨]之二 -15- 201132745 胺中之Ar。 3,5-二 X ’二硝基苄基醇列舉爲2,4-二硝基苄基醇、 硝基节基醇、2,5-二硝基苄基醇等。 [化9] Ο ο 〇<fH N〇2 或 ΟThe dinitro compound represented by the above formula [7] can be synthesized by esterification of the corresponding dinitrobenzyl alcohol as described below. Namely, it is synthesized by reacting dinitrobenzyl alcohol with carboxyphosphonium chloride or acid dianhydride in the presence of a base such as pyridine or triethylamine. Further, the Ar system corresponds to Ar in the amine of the above-mentioned general formula [丨] -15-201132745 which is the object of interest. The 3,5-di-X 'dinitrobenzyl alcohol is exemplified by 2,4-dinitrobenzyl alcohol, nitrohexyl alcohol, 2,5-dinitrobenzyl alcohol and the like. [化9] Ο ο 〇<fH N〇2 or Ο
鹼、溶劑 ^Ar > 〇2N~Cf $ &上述通式[7]表示之二硝基化合物還原, S式[1 ]袠示之二胺之方法並無特別限制,可藉由< 碳、氧化鉑、阮尼(Raney )鎳、鉛黑、鍺-氧化鋁 隹白碳等作爲觸媒,在乙酸乙酯、甲苯、四氫呋喃、 、醇系等溶劑中,與氫氣、聯胺、氯化氫等反應而 〈二胺成分〉 以上式[1]表示之二胺可進行與四羧酸二酐之 得聚醯胺酸。本發明中,合成聚醯胺酸時使用之二 可僅爲以式[1 ]表示之二胺,亦可組合由其他二胺 之一種或兩種以上。 至於二胺成分,可藉由含有以式[1]表示之二 高所得聚醯胺酸及使該聚醯胺酸進行醯亞胺化而成 亞胺對有機溶劑之溶解性。另外,由含有該聚醯胺 醯亞胺之液晶配向處理劑獲得之液晶配向膜之摩擦 異、電壓維持率高、且即使對液晶胞施加直流電壓 獲得以 £用鈀-、硫化 二噁烷 進行。 反應獲 胺成分 所選出 胺,提 之聚醯 酸或聚 耐性優 亦難以 -16- 201132745 引起初期之電荷累積。爲獲得該等特性,以式[1 ]表示之 二胺較好爲聚醯胺酸之合成中使用之二胺成分全部之 5〜1 0 0莫耳%,更好爲1 0〜8 0莫耳%,最好爲2 0〜5 0莫耳%。 上述之二胺成分中,與以式[1 ]表示之二胺之組合使 用之二胺並無特別限制。該等二胺之具體例示於下。 脂環式二胺之例列舉爲1,4-二胺基環己烷、1,3-二胺 基環己烷、4,4’-二胺基二環己基甲烷、4,4’-二胺基_3,3’-二甲基二環己胺、異佛爾酮二胺等。 芳香族二胺之例列舉爲鄰-苯二胺、間-苯二胺、對-苯二胺、2,4-二胺基甲苯、2,5-二胺基甲苯、3,5-二胺基 甲苯、3,5-二胺基43-二烯丙基苯胺、2,4-二胺基-1^,1^-二烯丙基苯胺、1,4-二胺基-2-甲氧基苯、2,5-二胺基-對-二甲苯、1,3-二胺基-4-氯苯、3,5-二胺基苯甲酸、1,4-二 胺基-2,5-二氯苯、4,4’-二胺基-1,2-二苯基乙烷、4,4’-二 胺基-2,2’-二甲基聯苄、4,4’-二胺基二苯基甲烷、3,3’-二 胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、4,4’-二胺基-3,3’-二甲基二苯基甲烷、2,2’-二胺基二苯乙烯、4,4’-二 胺基二苯乙烯、4,4’-二胺基二苯基醚、3,4’·二胺基二苯 基醚、4,4’-二胺基二苯基硫醚、4,4’-二胺基二苯基颯、 3,3’-二胺基二苯基颯、4,4’-二胺基二苯甲酮、1,3-雙(3-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙( 4-胺基苯氧基)苯、3,5-雙(4-胺基苯氧基)苯甲酸、 4,4’-雙(4-胺基苯氧基)聯苄、2,2-雙[(4-胺基苯氧基) 甲基]丙烷、2,2-雙[4-(4_胺基苯氧基)苯基]六氟丙烷、 -17- 201132745 2,2-雙[4- (4-胺基苯氧基)苯基]丙烷、雙[4- (3-胺基苯 氧基)苯基]颯、雙[4-(4-胺基苯氧基)苯基]颯、1,1-雙 (4-胺基苯基)環己烷、α,α’-雙(4-胺基苯基)-1,4-二異 丙基苯、9,9-雙(4-胺基苯基)苐、2,2-雙(3-胺基苯基 )六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、4,4’-二胺 基二苯基胺、2,4-二胺基二苯基胺、1,8-二胺基萘、1,5-二胺基萘、1,5-二胺基蒽、1,3-二胺基嵌二萘、1,6-二胺 基嵌二萘、1,8-二胺基嵌二萘、2,7-二胺基莽、1,3-雙(4-胺基苯基)四甲基二矽氧烷、聯苯胺、2,2’-二甲基聯苯胺 ' 1,2-雙(4-胺基苯基)乙烷、1,3-雙(4-胺基苯基)丙 烷、1,4-雙(4-胺基苯基)丁烷、1,5-雙(4-胺基苯基) 戊烷、1,6-雙(4-胺基苯基)己烷、1,7-雙(4-胺基苯基 )庚烷、1,8-雙(4-胺基苯基)辛烷、1,9-雙(4-胺基苯 基)壬烷、1,1〇_雙(4-胺基苯基)癸烷、1,3-雙(4-胺基 苯氧基)丙烷、1,4-雙(4-胺基苯氧基)丁烷、1,5-雙( 4-胺基苯氧基)戊烷、1,6-雙(4-胺基苯氧基)己烷、 1,7-雙(4-胺基苯氧基)庚烷、1,8-雙(4-胺基苯氧基) 辛烷、1,9_雙(4-胺基苯氧基)壬烷、1,10-雙(4-胺基苯 氧基)癸烷、二(4-胺基苯基)丙-1,3-二酸酯、二(4-胺 基苯基)丁 -1,4-二酸酯、二(4-胺基苯基)戊-1,5-二酸酯 、二(4 -胺基苯基)己-1,6 -二酸酯、二(4 -胺基苯基) 庚-1,7-二酸酯 '二(4-胺基苯基)辛-1,8-二酸酯、二(4-胺基苯基)壬-1,9-二酸酯、二(4-胺基苯基)癸-1,10-二 酸酯、1,3-雙[4-(4-胺基苯氧基)苯氧基]丙烷、1,4-雙 -18- 201132745 [4- ( 4_胺基苯氧基)苯氧基]丁烷、1,5-雙[4- ( 4-胺基苯 氧基)苯氧基]戊烷、1,6-雙[4-(4-胺基苯氧基)苯氧基] 己烷、1,7-雙[4-(4-胺基苯氧基)苯氧基]庚烷、1,8-雙 [4· (4_胺基苯氧基)苯氧基]辛烷、1,9-雙[4-(4·胺基苯 氧基)苯氧基]壬烷、1,1〇-雙[4- (4-胺基苯氧基)苯氧基 ]癸烷等。 雜環式二胺之例列舉爲2,6-二胺基吡啶、2,4-二胺基 吡啶、2,4-二胺基-1,3,5-三嗪、2,7-二胺基二苯并呋喃、 3,6-二胺基昨唑、2,4-二胺基-6-異丙基-1,3,5-三嗪、2,5-雙(4-胺基苯基)-1,3,4-噁二唑等。 脂肪族二胺之例列舉爲1,2-二胺基乙烷、1,3-二胺基 丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己 烷、1,7-二胺基庚烷、1,8-二胺基辛烷、U9-二胺基壬烷 、1,10 -二胺基癸烷、1,3-二胺基- 2,2-二甲基丙烷、1,6-二 胺基-2,5-二甲基己烷、1,7-二胺基-2,5-二甲基庚烷、1,7-二胺基-4,4-二甲基庚烷、1,7-二胺基-3-甲基庚烷、1,9-二 胺基-5-甲基庚烷、1,12-二胺基十二碳烷、1,18-二胺基十 八碳烷、1,2-雙(3-胺基丙氧基)乙烷等。 芳香族-脂肪族二胺之例列舉爲以式[3 ]表示之二胺。 Η 2 N — A r ’ 一 R 1 — N Η — R 2 [3] 其中,式中之Ar’表示伸苯基或伸萘基’ I表示碳數 1~5,較好1〜3之伸院基,R2表示氫原子或碳數1~5之院基 ,較好爲氫原子或甲基。 以式[3]表示之二胺之具體例列舉爲3-胺基苄基胺、4- -19- 201132745 胺基苄基胺' 3-胺基-N-甲基苄基胺、4·胺基-N-甲基苄基 胺、3-胺基苯乙基胺、4·胺基苯乙基胺、3-胺基-N-甲基苯 乙基胺、4 -胺基-N -甲基苯乙基胺、3- (3·胺基丙基)苯胺 、4-(3-胺基丙基)苯胺、3-(3-甲胺基丙基)苯胺、4-(3-甲胺基丙基)苯胺、3-(4-胺基丁基)苯胺、4-(4-胺基丁基)苯胺、3- ( 4-甲胺基丁基)苯胺、4- ( 4-甲胺 基丁基)苯胺、3- ( 5-胺基戊基)苯胺、4_ ( 5-胺基戊基 )苯胺、3-(5-甲胺基戊基)苯胺、4-(5-甲胺基戊基) 苯胺、2- ( 6-胺基萘基)甲基胺、3- ( 6-胺基萘基)甲基 胺、2- ( 6-胺基萘基)乙基胺、3- ( 6-胺基萘基)乙基胺 等。 以式[3]表示二胺與以式[1]表示之二胺倂用時,由於 進一步提高所得聚醯胺酸或聚醯亞胺(以下稱該等爲聚合 物)對有機溶劑之溶解性,且作爲液晶配向膜使用時之液 晶配向性優異故較佳。另外,倂用後述之加大液晶預傾角 之二胺(以下亦稱爲傾斜二胺)時,可達到進一步加大液 晶預傾角之效果。因此,於欲獲得相同大小之預傾角時, 即使傾斜二胺之使用量少亦可獲得大的傾角。此外,亦可 期待液晶配向處理劑印刷性之改善。 以式[3]表示之二胺之較佳含量爲二胺成分全部之 10~80莫耳%,較好爲20〜70莫耳%。 至於可加大液晶預傾角之二胺(亦稱爲傾斜二胺)可 列舉爲具有長鏈院基、全氟院基、芳香族環狀基、脂肪族 環狀基、或組合該等之取代基、類固醇骨架基等之二胺。 -20- 201132745 該等二胺可與以式[1 ]表示之二胺倂用。 以下列舉傾斜二胺之具體例,但本發明並不限於該等 。又,以下例示之式[12]〜式[38]中,j表示5〜20之整數,k 表示1~20之整數。 [化 10] NH h2n-^^- 0(CH2)jCH3 [12]Alkali, solvent ^Ar > 〇2N~Cf $ & The above formula [7] represents the reduction of the dinitro compound, and the method of the diamine represented by the formula [1] is not particularly limited, and may be carried out by < Carbon, platinum oxide, Raney nickel, lead black, lanthanum-alumina, white carbon, etc. as a catalyst, in a solvent such as ethyl acetate, toluene, tetrahydrofuran, or alcohol, with hydrogen, hydrazine, hydrogen chloride (Diamine component) The diamine represented by the above formula [1] can be obtained as a polyamine derivative with a tetracarboxylic dianhydride. In the present invention, the diamine used in the synthesis of polyamic acid may be only a diamine represented by the formula [1], or one or more of the other diamines may be combined. As for the diamine component, the solubility of the imine in an organic solvent can be obtained by containing the polypyridic acid obtained by the formula [1] and the imidization of the polyamine. Further, the liquid crystal alignment film obtained from the liquid crystal alignment treatment agent containing the polyamidoximine has a high frictional value and a high voltage holding ratio, and even if a direct current voltage is applied to the liquid crystal cell, it is obtained by using palladium- or dioxane sulfide. . The amine obtained by the reaction is selected as the amine, and the polypyruic acid or the poly-resistance is also difficult. -16-201132745 causes initial charge accumulation. In order to obtain such characteristics, the diamine represented by the formula [1] is preferably a total of 5 to 1% by mole of the diamine component used in the synthesis of the polyamic acid, more preferably 1 0 to 8 0 Ear %, preferably 2 0~5 0 mol%. Among the above diamine components, the diamine used in combination with the diamine represented by the formula [1] is not particularly limited. Specific examples of such diamines are shown below. Examples of alicyclic diamines are 1,4-diaminocyclohexane, 1,3-diaminocyclohexane, 4,4'-diaminodicyclohexylmethane, 4,4'-di Amino-3,3'-dimethyldicyclohexylamine, isophoronediamine, and the like. Examples of aromatic diamines are o-phenylenediamine, m-phenylenediamine, p-phenylenediamine, 2,4-diaminotoluene, 2,5-diaminotoluene, 3,5-diamine. Toluene, 3,5-diamino43-diallylaniline, 2,4-diamino-1,1^-diallylaniline, 1,4-diamino-2-methoxy Benzobenzene, 2,5-diamino-p-xylene, 1,3-diamino-4-chlorobenzene, 3,5-diaminobenzoic acid, 1,4-diamino-2,5 -dichlorobenzene, 4,4'-diamino-1,2-diphenylethane, 4,4'-diamino-2,2'-dimethylbibenzyl, 4,4'-di Aminodiphenylmethane, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 4,4'-diamino-3,3'-dimethyl Diphenylmethane, 2,2'-diaminostilbene, 4,4'-diaminostilbene, 4,4'-diaminodiphenyl ether, 3,4'.diamine Diphenyl ether, 4,4'-diaminodiphenyl sulfide, 4,4'-diaminodiphenylanthracene, 3,3'-diaminodiphenylanthracene, 4,4'- Diaminobenzophenone, 1,3-bis(3-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-amino group) Phenoxy)benzene, 3,5-bis(4-aminophenoxy) Benzoic acid, 4,4'-bis(4-aminophenoxy)bibenzyl, 2,2-bis[(4-aminophenoxy)methyl]propane, 2,2-bis[4-( 4-aminophenoxy)phenyl]hexafluoropropane, -17- 201132745 2,2-bis[4-(4-aminophenoxy)phenyl]propane, bis[4-(3-amino) Phenoxy)phenyl]anthracene, bis[4-(4-aminophenoxy)phenyl]anthracene, 1,1-bis(4-aminophenyl)cyclohexane, α,α'-double (4-Aminophenyl)-1,4-diisopropylbenzene, 9,9-bis(4-aminophenyl)anthracene, 2,2-bis(3-aminophenyl)hexafluoropropane , 2,2-bis(4-aminophenyl)hexafluoropropane, 4,4'-diaminodiphenylamine, 2,4-diaminodiphenylamine, 1,8-diamino Naphthalene, 1,5-diaminonaphthalene, 1,5-diaminostilbene, 1,3-diamine-xylene, 1,6-diaminopyrene, 1,8-diamine Diphthalaphthalene, 2,7-diaminoguanidine, 1,3-bis(4-aminophenyl)tetramethyldioxane, benzidine, 2,2'-dimethylbenzidine 1, 2 - bis(4-aminophenyl)ethane, 1,3-bis(4-aminophenyl)propane, 1,4-bis(4-aminophenyl)butane, 1,5-bis ( 4-aminophenyl)pentane, 1,6-bis(4-amine Phenyl)hexane, 1,7-bis(4-aminophenyl)heptane, 1,8-bis(4-aminophenyl)octane, 1,9-bis(4-aminophenyl) ) decane, 1,1 〇 bis(4-aminophenyl) decane, 1,3-bis(4-aminophenoxy)propane, 1,4-bis(4-aminophenoxy) Butane, 1,5-bis(4-aminophenoxy)pentane, 1,6-bis(4-aminophenoxy)hexane, 1,7-bis(4-aminophenoxyl) Heptane, 1,8-bis(4-aminophenoxy)octane, 1,9-bis(4-aminophenoxy)decane, 1,10-bis(4-aminobenzene Oxy) decane, bis(4-aminophenyl)propane-1,3-dicarboxylate, bis(4-aminophenyl)butane-1,4-dicarboxylate, di(4-amino) Phenyl)penta-1,5-diester, bis(4-aminophenyl)hex-1,6-dicarboxylate, bis(4-aminophenyl)heptane-1,7-dicarboxylate 'Bis(4-aminophenyl)octane-1,8-diester, bis(4-aminophenyl)phosphonium-1,9-dicarboxylate, bis(4-aminophenyl)fluorene- 1,10-diester, 1,3-bis[4-(4-aminophenoxy)phenoxy]propane, 1,4-bis-18- 201132745 [4-(4-aminophenoxy) Phenoxy]butane, 1,5-bis[4- ( 4- Phenoxy)phenoxy]pentane, 1,6-bis[4-(4-aminophenoxy)phenoxy]hexane, 1,7-bis[4-(4-aminobenzene) Oxy)phenoxy]heptane, 1,8-bis[4·(4-aminophenoxy)phenoxy]octane, 1,9-bis[4-(4.aminophenoxy) Phenoxy]decane, 1,1 fluorene-bis[4-(4-aminophenoxy)phenoxy]nonane, and the like. Examples of heterocyclic diamines are 2,6-diaminopyridine, 2,4-diaminopyridine, 2,4-diamino-1,3,5-triazine, 2,7-diamine. Dibenzofuran, 3,6-diaminocarbazol, 2,4-diamino-6-isopropyl-1,3,5-triazine, 2,5-bis(4-aminobenzene Base)-1,3,4-oxadiazole and the like. Examples of aliphatic diamines are 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6 -diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, U9-diaminodecane, 1,10-diaminodecane, 1,3-di Amino-2,2-dimethylpropane, 1,6-diamino-2,5-dimethylhexane, 1,7-diamino-2,5-dimethylheptane, 1, 7-Diamino-4,4-dimethylheptane, 1,7-diamino-3-methylheptane, 1,9-diamino-5-methylheptane, 1,12- Diaminododecane, 1,18-diaminooctadecane, 1,2-bis(3-aminopropoxy)ethane, and the like. Examples of the aromatic-aliphatic diamine are exemplified by the diamine represented by the formula [3]. Η 2 N — A r ' - R 1 — N Η — R 2 [3] wherein Ar' represents a phenyl or anthranyl group 'I represents a carbon number of 1 to 5, preferably 1 to 3 In the hospital base, R2 represents a hydrogen atom or a courtyard group having a carbon number of 1 to 5, preferably a hydrogen atom or a methyl group. Specific examples of the diamine represented by the formula [3] are exemplified by 3-aminobenzylamine, 4--19-201132745 aminobenzylamine '3-amino-N-methylbenzylamine, 4·amine --N-methylbenzylamine, 3-aminophenethylamine, 4·aminophenethylamine, 3-amino-N-methylphenethylamine, 4-amino-N-methyl Phenylethylamine, 3-(3.Aminopropyl)aniline, 4-(3-aminopropyl)aniline, 3-(3-methylaminopropyl)aniline, 4-(3-methylamine Propyl)aniline, 3-(4-aminobutyl)aniline, 4-(4-aminobutyl)aniline, 3-(4-methylaminobutyl)aniline, 4-(4-methylamine Benzyl)aniline, 3-(5-aminopentyl)aniline, 4-(5-aminopentyl)aniline, 3-(5-methylaminopentyl)aniline, 4-(5-methylamino) Amyl) aniline, 2-(6-aminonaphthyl)methylamine, 3-(6-aminonaphthyl)methylamine, 2-(6-aminonaphthyl)ethylamine, 3-( 6-Aminonaphthyl)ethylamine and the like. When the diamine and the diamine oxime represented by the formula [1] are represented by the formula [3], the solubility of the obtained polyglycolic acid or polyimine (hereinafter referred to as a polymer) in an organic solvent is further improved. Further, it is preferable because it is excellent in liquid crystal alignment when used as a liquid crystal alignment film. Further, when the diamine (hereinafter also referred to as a tilted diamine) which increases the pretilt angle of the liquid crystal described later is used, the effect of further increasing the liquid crystal pretilt angle can be attained. Therefore, when a pretilt angle of the same size is to be obtained, a large inclination angle can be obtained even if the amount of the tilted diamine used is small. Further, improvement in printability of the liquid crystal alignment treatment agent can be expected. The preferred content of the diamine represented by the formula [3] is 10 to 80 mol%, preferably 20 to 70 mol%, based on the total amount of the diamine component. As for the diamine (also referred to as a tilted diamine) which can increase the pretilt angle of the liquid crystal, it can be exemplified by having a long chain building group, a perfluoro yard group, an aromatic cyclic group, an aliphatic cyclic group, or a combination thereof. a diamine such as a steroid skeleton or the like. -20- 201132745 These diamines can be used together with the diamines represented by the formula [1]. Specific examples of the inclined diamine are listed below, but the present invention is not limited to these. Further, in the following formulas [12] to [38], j represents an integer of 5 to 20, and k represents an integer of 1 to 20. [Chemical 10] NH h2n-^^- 0(CH2)jCH3 [12]
H2N nh2 h2n-hQ> NH2 0~O~O_(cH2)kCH3 [14] nh2 0_O~O~〇(CH2)kCH3 [13]H2N nh2 h2n-hQ> NH2 0~O~O_(cH2)kCH3 [14] nh2 0_O~O~〇(CH2)kCH3 [13]
H2NH2N
(CH2)kCH3 [15] -21 - 201132745 [化 11] nh2 H2N-^^ [16] 0(CH2)kCH3 〇 H2(CH2)kCH3 [15] -21 - 201132745 [化11] nh2 H2N-^^ [16] 0(CH2)kCH3 〇 H2
n/Cv^v〇(CH2)kCH3 V 【171 NH2 0(CH2)kCH3n/Cv^v〇(CH2)kCH3 V [171 NH2 0(CH2)kCH3
[化 12] nh2[化 12] nh2
H2NH2N
[19][19]
-22- 201132745 [化 13]-22- 201132745 [Chem. 13]
(CH2)kCH3 [22] (CHACHs [23](CH2)kCH3 [22] (CHACHs [23]
[2句 [化 14][2 sentences [化14]
[30][30]
nh2 cH NH2 ~QrQrw (CH2)kCH3 [31] -23- 201132745 [化 15]Nh2 cH NH2 ~QrQrw (CH2)kCH3 [31] -23- 201132745 [Chem. 15]
[34] (Cri^CHa[34] (Cri^CHa
[化 16][Chemistry 16]
上述式[12]〜式[38]之二胺中,式[12]之二胺由於液晶 配向性優異故較佳。式[1 9 ]〜式[2 6 ]之二胺由於預傾角之展 現能極高,故可較好地使用於〇CB ( Optically -24- 201132745Among the diamines of the above formulas [12] to [38], the diamine of the formula [12] is preferred because it is excellent in liquid crystal alignment. The diamine of the formula [1 9 ]~[2 6 ] can be preferably used in 〇CB ( Optically -24- 201132745) because of the extremely high pretilt angle.
Compensated Bend ’光學補償彎曲)液晶用配向膜(〇cB 用配向膜)、垂直配向模式液晶用配向膜(VA用配向膜 )° 例如,於TN液晶用配向膜(預傾角3〜5。),式[1 2 ]之 二胺含量較好爲二胺成分全部之10〜30莫耳%,於OCB用 配向膜或VA用配向膜(預傾角1〇〜90。),式[19]〜式[26] 之二胺含量較好爲二胺成分全部之5〜40莫耳%。 考慮本發明之液晶配向處理劑中使用之聚醯胺酸或聚 醯亞胺之溶解性、液晶之配向性、傾角、電壓維持率、累 積電荷等各種特性之均衡時,使用例如以式[1 ]、式[3 ]及 式[12]表示之二胺成分時,各二胺成分之較佳比率以莫耳 比較好爲 1 0〜50% (式[1] ) /20~80% (式[3] ) /10~30% (式 [12]),更好爲 20〜40% (式[1] ) /30〜50% (式[3]) /10~30% (式[12])。 〈四羧酸二酐成分〉 本發明之液晶配向處理劑中必要之聚醯胺酸或聚醯亞 胺中,與上述二胺成分反應之四羧酸二酐成分並無特別限 制。亦即,可爲一種四羧酸二酐,亦可倂用兩種以上之四 羧酸二酐。 本發明之液晶配向處理劑中,就進一步提高液晶胞之 電壓維持率之觀點而言,較好使用具有脂環式構造或脂肪 族構造之四羧酸二酐作爲與前述二胺成分反應之四羧酸二 酐。 -25- 201132745 具有脂環式構造或脂肪族構造之四羧酸二酐列舉爲 1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四 羧酸二酐、1,3·二甲基-1,2,3,4-環丁烷四羧酸二酐、 1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊 烷四羧酸二酐、2,3,4,5-四氫呋喃四羧酸二酐、1,2,4,5-環 己烷四羧酸二酐、3,4-二羧基-1-環己基琥珀酸二酐、3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸二酐、[4-(2,5-二氧代四 氫呋喃-3-基)-1,2,3,4-四氫萘-1,2-二羧酸酐]、1,2,3,4-丁 烷四羧酸二酐、雙環[3.3.0]辛烷-2,4,6,8-四羧酸二酐、 3,3’,4,4’-二環己基四羧酸二酐、2,3,5-三羧基環戊基乙酸 二酐、順式-3,7-二丁基環辛-1,5-二烯-1,2,5,6-四羧酸二酐 、三環[4.2.1.02.5]壬烷-3,4,7,8-四羧酸-3,4: 7,8-二酐、六 環[6.6.0.12,7.03,6.19,14.010.13]十六碳烷-4,5,11,12-四羧 狻-4,5:11,12-二酐等。其中,尤其使用1,2,3,4-環丁烷四 羧酸二酐時可獲得液晶配向性優異之配向膜故而較佳。 進而’倂用芳香族四羧酸二酐時,可改善液晶配向性 ,且可加速液晶胞之累積電荷之去除。芳香族四羧酸二酐 列舉爲均苯四酸二酐、3,3’,4,4’-聯苯四羧酸二酐、 2,2 ’,3,3 ’ -聯苯四羧酸二酐、2,3,3 ’ 4 _聯苯四羧酸二酐、 3,3’,4,4’-二苯甲酮四羧酸二酐、2,3,3’,4-二苯甲酮四羧酸 二酐、雙(3,4-二羧基苯基)醚二酐、雙(3,4-二羧基苯 基)颯二酐、1,2,5,6_萘四羧酸二酐、2,3,6,7-萘四羧酸二 酐等。其中以均苯四酸二酐最好。 若考慮所得聚醯胺酸或聚醯亞胺之溶解性、液晶配向 -26- 201132745 性、電壓維持率、累積電荷等各種特性之均衡’具有脂環 式構造或脂肪族構造之四羧酸二酐與芳香族四羧酸二酐之 使用比率以前者/後者之莫耳比較好爲90/10〜50/50,更好 爲 80/20〜60/40 。 〈聚合反應〉 本發明中,四羧酸二酐成分與二胺成分之聚合反應方 法並無特別限制。一般而言,可藉由在有機溶劑中混合進 行聚合反應成爲聚醯胺酸,可藉由使該聚醯胺酸經脫水閉 環成爲聚醯亞胺。 使四羧酸二酐成分與二胺成分在有機溶劑中混合之方 法列舉爲攪拌使二胺成分分散或溶解於有機溶劑中而成之 溶液,直接添加四羧酸二酐成分或使之分散或溶解於有機 溶劑中添加之方法,相反地將二胺成分添加於將四羧酸二 酐成分分散或溶解於有機溶劑中而成之溶液中之方法,交 互添加四羧酸二酐成分與二胺成分之方法。又,四羧酸二 酐成分或二胺成分由複數種化合物組成時,可以預先混合 該等複數種成分之狀態進行聚合反應,亦可個別依序進行 聚合反應。 在有機溶劑中使四羧酸二酐與二胺成分進行聚合反應 時之溫度通常爲〇〜150°C,較好爲5~100°C,更好爲10~80°C 。溫度高時聚合反應提早結束,但太高時有無法獲得高分 子量之聚合物之情況。 又,聚合反應可以任意濃度進行,但四羧酸二酐與二 -27- 201132745 胺成分之合計濃度太低時難以獲得高分子量之聚合物,濃 度太高時反應液之黏性過高導致難以均勻攪拌,故合計濃 度較好爲卜50質量%,更好爲5〜30質量%。聚合反應初期 亦可以高濃度進行,隨後追加有機溶劑。 上述聚合反應時使用之有機溶劑只要使產生之聚醯胺 酸溶解者即無特別限制。若列舉其具體例,則可列舉爲 N,N -二甲基甲醯胺、N,N -二甲基乙醯胺、N -甲基-2 -吡咯 烷酮、N-乙基-2-吡咯烷酮、N-甲基己內醯胺、二甲基亞 楓、四甲基脲、吡啶、二甲基颯、六甲基亞颯、γ-丁內酯 、1,3·二甲基咪唑啶酮等。該等可單獨使用,亦可混合使 用。而且,即使爲無法溶解聚醯胺酸之溶劑,在不使生成 之聚醯胺酸析出之範圍內,亦可混合於上述溶劑中使用。 又,有機溶劑中之水份爲妨礙聚合反應,進而使生成之聚 醯胺酸水解之原因,故有機溶劑儘量使用經脫水乾燥者。 聚醯胺酸之聚合反應所使用之四羧酸二酐成分與二胺 成分之比率以莫耳比較好爲1 : 0.8〜1 : 1.2,該莫耳比越 接近於1 : 1時,所得聚醯胺酸之分子量變大。藉由控制該 聚醯胺酸之分子量,可調整醯亞胺化後所得之聚醯胺之分 子量。 本發明之聚醯胺酸或聚醯亞胺之分子量並無特別限制 ,但含於液晶配向處理劑中時,就所得塗膜之強度與作爲 液晶配向處理劑之操作容易之觀點而言,重量平均分子量 較好爲 2,000~200,000,更好爲 5,000〜50,000。 -28- 201132745 〈聚醯亞胺之合成〉 本發明之液晶配向處理劑中使用之聚醯亞胺爲使上述 之聚醯胺酸進行醯亞胺化而成之聚醯亞胺。聚醯胺酸之醯 亞胺化可藉由在有機溶劑中,於鹼性觸媒與酸酐存在下攪 拌1〜1 0 0小時。 鹼性觸媒可列舉爲吡啶、三乙胺、三甲基胺、三丁基 胺、三辛基胺等。其中吡啶由於具有進行反應之適當鹼性 故較佳。 又,酸肝可列舉爲乙酸酌1、偏苯三酸酐、均苯四酸酐 等。其中乙酸酐於醯亞胺化結束後,所得聚醯亞胺之純化 變得容易故較佳。 有機溶劑可使用前述聚醯胺酸聚合反應時使用之溶劑 〇 聚醯亞胺之醯亞胺化率可藉由調節觸媒量、反應溫度 、反應時間等加以控制。此時之鹼性觸媒之量較好爲醯胺 酸基之0.2〜10倍莫耳,更好爲0.5〜5倍莫耳。又,酸酐之 量較好爲醯胺酸基之1〜30倍莫耳,更好爲1〜10倍莫耳。反 應溫度較好爲-20~25 0°C,更好爲0〜180°C。 本發明之液晶配向處理劑中使用之聚醯亞胺之醯亞胺 化率並無特別限制,但基於獲得更高電壓維持率之液晶配 向膜之理由,醯亞胺化率較好爲4 0 %以上,更好爲6 0 %以 上,最好爲80%以上。 如此獲得之聚醯亞胺之溶液由於殘留有添加之觸媒等 ,故用於液晶配向處理劑時,較好將聚醯亞胺回收•洗淨 -29- 201132745 後使用。 聚醯亞胺之回收可將醯亞胺化後之溶液倒入攪拌下之 弱溶劑中,於析出聚醯亞胺後經過濾。此時之弱溶劑可列 舉爲甲醇 '丙酮、己烷、丁基溶纖素、庚烷、甲基乙基酮 、甲基異丁基酮、乙醇、甲苯、苯等。回收之聚醯亞胺之 洗淨亦可以該弱溶劑進行。如此回收•洗淨之聚醯亞胺可 在常壓或減壓下,經常溫或加熱乾燥成爲粉末。 該等操作亦可對前述聚醯胺酸進行。例如,不使聚醯 胺酸之聚合所用之溶劑含於液晶配向處理劑中時,或去除 反應溶液中之未反應單體成分或雜質時,進行上述之沉澱 回收及純化即可》 〈液晶配向處理劑〉 本發明之液晶配向處理劑爲含有如上述獲得之聚醯胺 酸及聚醯亞胺中之至少一種聚合物之塗佈液。 列舉其製造例時,可使前述聚醯胺酸或聚醯亞胺之反 應溶液直接或稀釋者,亦可使自反應液沉澱回收者再溶解 於有機溶劑中。又’稀釋或再溶解步驟中’可進行用以控 制對基板之塗佈性之溶劑組成調整或用以改善塗膜特性之 添加物之追加。進而,亦可添加與上述不同構造之聚醯亞 胺溶液或聚醯胺酸之溶液混合之其他樹脂。 上述之稀釋或再溶解步驟中使用之有機溶劑只要使含 有之聚合物溶解者即無特別限制。列舉其具體例爲N,N-二 甲基甲醯胺、Ν,Ν·二甲基乙醯胺、N-甲基-2-吡咯烷酮、 -30- 201132745 N -甲基己內醯胺、2 -吡咯烷酮、N -乙基-2-吡咯烷酮、N-乙烯基吡咯烷酮、二甲基亞颯、四甲基脲、二甲基颯、六 甲基亞砸、γ -丁內酯、1,3 -二甲基咪唑啶酮等。其中,以 Ν-甲基-2-吡咯烷酮、Ν-乙基-2-吡咯烷酮、l,3-二甲基咪 唑啶酮、γ -丁內酯較適用。該等可單獨使用一種或混合兩 種以上使用。 控制液晶配向處理劑對基板之塗佈性而添加之溶劑列 舉爲乙基溶纖素、丁基溶纖素、乙基卡必醇、丁基卡必醇 、乙基卡必醇乙酸酯、乙二醇、卜甲氧基-2-丙醇' 1-乙氧 基-2-丙醇、1-丁氧基-2-丙醇、1·苯氧基-2-丙醇、二乙二 醇二乙基醚、丙二醇單乙酸酯、丙二醇二乙酸酯、二丙二 醇單甲基醚、丙二醇-1-單甲基醚-2_乙酸酯、丙二醇-1-單 乙基醚-2-乙酸酯、二丙二醇、2- (2-乙氧基丙氧基)丙醇 、乳酸甲酯、乳酸乙酯、乳酸正丙酯、乳酸正丁酯、乳酸 異戊酯等。該等溶劑中,亦可含有以單獨無法溶解聚醯胺 酸或聚醯亞胺之溶劑,但只要在不使聚合物析出之範圍, 均可混合於本發明之液晶配向處理劑中。尤其,藉由適度 混合具有低表面張力之溶劑,可改善對基板塗佈時之塗膜 均勻性,亦可適用於本發明之液晶配向處理劑中。其中, 尤其就聚醯亞胺之溶解性之觀點而言,最好爲丁基溶纖素 、乙基卡必醇、二丙二醇單甲基醚、二乙二醇二乙基醚。 用以改善塗膜特性之添加物列舉爲3 -胺基丙基甲基二 乙氧基矽烷、3 -苯基胺基丙基三甲氧基矽烷、3 -胺基丙基 三乙氧基矽烷、(胺基乙基胺基甲基)苯乙基三甲氧基矽 -31 - 201132745 烷等矽烷偶合劑。藉由添加該等矽烷偶合劑,可改善塗膜 對基板之密著性,但添加量過大時,容易造成聚醯胺酸或 聚醯亞胺等之凝聚。因此,矽烷偶合劑之含量相對於聚醯 胺酸及聚醯亞胺之合計質量較好爲0.5〜10質量%,更好爲 1〜5質量°/〇。 本發明之液晶配向處理劑之固體成分濃度可依據形成 之液晶配向膜厚度之設定適宜改變,但較好爲1〜10質量% 。未達1質量%時難以形成均勻無缺陷之塗膜,多於10質 量%時會有溶液儲存安定性惡化之情況。此處所謂的固體 成分係指自液晶配向處理劑去除溶劑者。又,本發明之液 晶配向處理劑中使用之聚醯胺酸或聚醯亞胺之濃度並無特 別限制,但就所得液晶配向膜特性之觀點而言,較好爲1 質量%以上,更好爲3質量%以上,最好爲5質量%以上。 以上獲得之液晶配向處理劑在塗佈於基板之前較好經 過爐。 〈液晶顯示元件〉 本發明之液晶配向處理劑可塗佈於基板上,並經乾燥 、燒成成爲塗膜,且藉由摩擦處理該塗膜面,作爲摩擦用 之液晶配向膜使用。又亦可未經摩擦處理作爲VA用(垂 直配向用)液晶配向膜、光配向膜使用。 此時,使用之基板只要是透明性高之基板則無特別限 制,可使用玻璃基板、丙烯酸基板或聚碳酸酯基板等塑膠 基板等,就製程簡化之觀點而言,以使用形成有液晶驅動 -32- 201132745 用之ITO電極等基板較佳。又,反射型液晶顯示元件亦可 使用僅在單面之基板上使用矽晶圓等不透明物,該情況之 電極亦可使用鋁等反射光之材料。 液晶配向處理劑之塗佈方法列舉爲旋轉塗佈法、印刷 法、噴墨法等,但就生產性方面而言,工業上廣泛使用軟 版印刷法,且亦適用於本發明之液晶配向處理劑。 塗佈液晶配向處理劑後之乾燥步驟未必需要,但自塗 佈後至燒成之時間對每一基板並不一定時,或塗佈後並未 立即燒成時,較好包含乾燥步驟。乾燥較好使溶劑蒸發至 不會因基板之運送使塗膜形狀變形之程度,其乾燥手段並 無特別限制,列舉爲例如在50~150°c,較好80〜120°c之加 熱板上乾燥0.5〜30分鐘,較好乾燥1~5分鐘之方法。 塗佈液晶配向處理劑之基板的燒成較好以1 00〜3 50°C 之任意溫度進行,但更好爲150〜3 00 °C ,又更好爲 18 0〜2 5 0 °C。液晶配向處理劑中存在醯胺酸基時,依據該 燒成自醯胺酸轉化成醯亞胺之轉化率發生變化,但本發明 之液晶配向處理劑未必需要1 00%醯亞胺化。 燒成後之塗膜厚度太厚時就液晶顯示元件之耗電方面 不利,太薄時會有液晶顯示元件之信賴性下降之情況,故 較好爲10〜200nm,更好爲50〜100nm。 .如上述在基板上形成之塗膜面之摩擦處理可使用現有 之摩擦裝置。此時之摩擦布之材質列舉爲棉、嫘縈、尼龍 等》 以上述手法獲得之貼附液晶配向膜之基板可以習知方 -33- 201132745 法製作液晶胞,且成爲液晶顯示元件 之一例,一般係將形成液晶配向醇 1〜30μηι,更好2~10μηι之間隔挾持 〇〜2 7 0°之任意角度之方向設置且以密 液晶並密封之方法。液晶封入之方法 示爲使製作之液晶胞內減壓後注入液 晶後進行密封之滴加(ODF )法等。 如此獲得之液晶顯示元件適用5 、STN液晶顯示元件、TFT液晶顯示 元件,進而橫電場型(IPS )液晶顯; 元件等各種方式之顯示元件中。 實施例 以下列舉實施例,更詳細說明本 解釋爲限於該等。 (合成例1 ) 苯甲酸3,5-二胺基苄基酯之合成 於500mL之四頸燒瓶中,將吡啶 硝基苄基醇20.0g、苯甲醯氯14.9g、 液中,在室溫攪拌30小時。反應結异 攪拌1小時》添加乙酸乙酯萃取有機ϋ 碳酸氫鈉水溶液、飽和食鹽水洗淨有 添加於有機層中脫水乾燥,經過濾後 。若列舉液晶胞製作 :之一對基板以較好 ,以使摩擦方向成 封劑固定周圍,注入 並無特別限制,可例 晶之真空法,滴加液 >以ΤΝ液晶顯示元件 元件、Ο C Β液晶顯示 R元件、VA液晶顯示 發明,但本發明不應 8.8g滴加於含3,5-二 四氫呋喃150mL之溶 ί後,添加純水5 0 m L I,以1N鹽酸、飽和 機層。將無水硫酸鎂 ,使用旋轉蒸發器進 -34- 201132745 行溶劑之餾除。使用乙酸乙酯使殘留物進行再結晶,合成 24.9g之具有下述NMR特性之二硝基化合物(收率82%)。 'H NMR (400 MHz,CDC13) : δ 9.03 (t, 1H), 8.65 (d, 2H), 8.12-8.07 (m, 2H), 7.63 (tt, 1H), 7.5 3-7.47 (m, 2H), 5.55 (s, 2H)。 [化 17]Compensated Bend 'optical compensation bending' alignment film for liquid crystal (alignment film for 〇cB), alignment film for vertical alignment mode liquid crystal (alignment film for VA)° For example, for alignment film of TN liquid crystal (pretilt angle 3 to 5), The diamine content of the formula [1 2 ] is preferably from 10 to 30 mol% of the total diamine component, in the alignment film for OCB or the alignment film for VA (pretilt angle: 1 to 90), and the formula [19] The diamine content of [26] is preferably from 5 to 40 mol% of the total diamine component. In consideration of the balance of various properties such as solubility of polyphthalic acid or polyimine used in the liquid crystal alignment agent of the present invention, alignment property of liquid crystal, tilt angle, voltage maintenance ratio, and accumulated electric charge, for example, the formula [1] is used. In the case of the diamine component represented by the formula [3] and the formula [12], the preferred ratio of each diamine component is preferably from 10 to 50% by mol [Equation [1]) / 20 to 80% (formula) [3] ) /10~30% (form [12]), more preferably 20~40% (form [1]) / 30~50% (form [3]) /10~30% (form [12] ). <Tetracarboxylic acid dianhydride component> The polycarboxylic acid or polyimine which is required for the liquid crystal alignment treatment agent of the present invention, the tetracarboxylic dianhydride component which is reacted with the above diamine component is not particularly limited. Namely, it may be a tetracarboxylic dianhydride or two or more kinds of tetracarboxylic dianhydrides. In the liquid crystal alignment treatment agent of the present invention, in order to further increase the voltage maintenance ratio of the liquid crystal cell, tetracarboxylic dianhydride having an alicyclic structure or an aliphatic structure is preferably used as the fourth reaction with the diamine component. Carboxylic dianhydride. -25- 201132745 The tetracarboxylic dianhydride having an alicyclic structure or an aliphatic structure is exemplified by 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl-1,2, 3,4-cyclobutanetetracarboxylic dianhydride, 1,3·dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl- 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 1 , 2,4,5-cyclohexanetetracarboxylic dianhydride, 3,4-dicarboxy-1-cyclohexyl succinic dianhydride, 3,4-dicarboxy-1,2,3,4-tetrahydro- 1-naphthalene succinic dianhydride, [4-(2,5-dioxotetrahydrofuran-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic anhydride], 1,2 , 3,4-butane tetracarboxylic dianhydride, bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetra Carboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, cis-3,7-dibutylcyclooctane-1,5-diene-1,2,5,6-tetracarboxylic acid Acid dianhydride, tricyclo[4.2.1.02.5] decane-3,4,7,8-tetracarboxylic acid-3,4: 7,8-dianhydride, hexacyclo[6.6.0.12, 7.03, 6.19, 14.010.13] Hexadecane-4,5,11,12-tetracarboxyindole-4,5:11,12-dianhydride and the like. Among them, in particular, when 1,2,3,4-cyclobutanetetracarboxylic dianhydride is used, an alignment film having excellent liquid crystal alignment property can be obtained, which is preferable. Further, when aromatic tetracarboxylic dianhydride is used, the liquid crystal alignment property can be improved, and the cumulative charge of the liquid crystal cell can be accelerated. The aromatic tetracarboxylic dianhydride is exemplified by pyromellitic dianhydride, 3,3',4,4'-biphenyltetracarboxylic dianhydride, 2,2 ',3,3 '-biphenyltetracarboxylic acid Anhydride, 2,3,3 ' 4 _biphenyltetracarboxylic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 2,3,3',4-diphenyl Ketotetracarboxylic dianhydride, bis(3,4-dicarboxyphenyl)ether dianhydride, bis(3,4-dicarboxyphenyl)ruthenic anhydride, 1,2,5,6-naphthalenetetracarboxylic acid Anhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, and the like. Among them, pyromellitic dianhydride is preferred. Considering the solubility of the obtained polyaminic acid or polyimine, the balance of various properties such as liquid crystal alignment -26-201132745, voltage maintenance rate, and accumulated charge, 'tetracarboxylic acid II having an alicyclic structure or an aliphatic structure The use ratio of the anhydride to the aromatic tetracarboxylic dianhydride is preferably 90/10 to 50/50, more preferably 80/20 to 60/40. <Polymerization reaction> In the present invention, the polymerization reaction method of the tetracarboxylic dianhydride component and the diamine component is not particularly limited. In general, the polymerization can be carried out by mixing in an organic solvent to form polylysine, which can be converted into a polyimine by dehydrating and blocking the polyamic acid. A method of mixing a tetracarboxylic dianhydride component and a diamine component in an organic solvent is a solution obtained by stirring or dissolving a diamine component in an organic solvent, and directly adding or dispersing a tetracarboxylic dianhydride component or a method of dissolving in an organic solvent, and conversely adding a diamine component to a solution obtained by dispersing or dissolving a tetracarboxylic dianhydride component in an organic solvent, and mutually adding a tetracarboxylic dianhydride component and a diamine The method of ingredients. Further, when the tetracarboxylic dianhydride component or the diamine component is composed of a plurality of compounds, the polymerization reaction may be carried out by mixing the plurality of components in advance, or the polymerization may be carried out in an orderly manner. The temperature at which the tetracarboxylic dianhydride and the diamine component are polymerized in an organic solvent is usually 〇 150 ° C, preferably 5 to 100 ° C, more preferably 10 to 80 ° C. When the temperature is high, the polymerization reaction ends early, but when it is too high, there is a case where a polymer having a high molecular weight cannot be obtained. Further, the polymerization reaction can be carried out at any concentration, but it is difficult to obtain a polymer having a high molecular weight when the total concentration of the tetracarboxylic dianhydride and the amine component of the second -27-201132745 is too low, and the viscosity of the reaction liquid is too high when the concentration is too high, resulting in difficulty in the reaction. The mixture is uniformly stirred, so that the total concentration is preferably 50% by mass, more preferably 5 to 30% by mass. The initial stage of the polymerization can also be carried out at a high concentration, followed by the addition of an organic solvent. The organic solvent used in the above polymerization reaction is not particularly limited as long as it dissolves the produced polyaminic acid. Specific examples thereof include N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, and N-ethyl-2-pyrrolidone. N-methyl caprolactam, dimethyl sulfoxide, tetramethyl urea, pyridine, dimethyl hydrazine, hexamethylarylene, γ-butyrolactone, 1,3-dimethylimidazolidone, etc. . These may be used alone or in combination. Further, even a solvent in which polylysine cannot be dissolved can be used in the above solvent without being precipitated in the range in which the produced polyaminic acid is precipitated. Further, since the water in the organic solvent is a cause of hindering the polymerization reaction and further hydrolyzing the produced polylysine, the organic solvent is used as far as possible for dehydration. The ratio of the tetracarboxylic dianhydride component to the diamine component used in the polymerization of polylysine is preferably 1: 0.8~1: 1.2, and the closer the molar ratio is to 1:1, the resulting poly The molecular weight of the proline acid becomes large. By controlling the molecular weight of the polyamine, the molecular weight of the polyamine obtained after the imidization can be adjusted. The molecular weight of the poly-proline or the polyimine of the present invention is not particularly limited, but when it is contained in a liquid crystal alignment treatment agent, the weight of the obtained coating film and the operation as a liquid crystal alignment treatment agent are easy. The average molecular weight is preferably from 2,000 to 200,000, more preferably from 5,000 to 50,000. -28-201132745 <Synthesis of Polyimine> The polyimine used in the liquid crystal alignment treatment agent of the present invention is a polyimine obtained by subjecting the above polyamine to ruthenium. The imidization of the polyaminic acid can be carried out by stirring in an organic solvent in the presence of a basic catalyst and an acid anhydride for 1 to 100 hours. The basic catalyst may, for example, be pyridine, triethylamine, trimethylamine, tributylamine or trioctylamine. Among them, pyridine is preferred because it has an appropriate basicity for carrying out the reaction. Further, the acid liver may be, for example, acetic acid, trimellitic anhydride or pyromellitic anhydride. Among them, after the end of the imidization of acetic anhydride, the purification of the obtained polyimine is easy and preferable. As the organic solvent, the solvent used in the polymerization of the above polylysine may be used. The yield of the hydrazine imine may be controlled by adjusting the amount of the catalyst, the reaction temperature, the reaction time, and the like. The amount of the alkaline catalyst at this time is preferably from 0.2 to 10 moles, more preferably from 0.5 to 5 moles, of the amidoxime group. Further, the amount of the acid anhydride is preferably from 1 to 30 moles, more preferably from 1 to 10 moles, per mole of the amidate group. The reaction temperature is preferably from -20 to 25 ° C, more preferably from 0 to 180 ° C. The ruthenium imidization ratio of the polyimine used in the liquid crystal alignment treatment agent of the present invention is not particularly limited, but the ruthenium imidation ratio is preferably 40 based on the reason of obtaining a liquid crystal alignment film having a higher voltage maintenance ratio. More than %, more preferably 60% or more, and most preferably 80% or more. The solution of the polyimine thus obtained is used as a liquid crystal alignment agent, and is preferably used after the liquid crystal alignment treatment agent is recovered and washed -29-201132745. The polyimine is recovered by pouring the ruthenium solution into a weak solvent under stirring and filtering after precipitation of the polyimide. The weak solvent at this time may be exemplified by methanol 'acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, and the like. The washing of the recovered polyimine can also be carried out with the weak solvent. The polyimine which is thus recovered and washed can be dried to a powder under normal pressure or reduced pressure at a constant temperature or heat. These operations can also be carried out on the aforementioned polylysine. For example, when the solvent used for the polymerization of the polyamic acid is not contained in the liquid crystal alignment treatment agent, or when the unreacted monomer component or impurities in the reaction solution are removed, the above-mentioned precipitation recovery and purification can be performed. Treatment agent> The liquid crystal alignment treatment agent of the present invention is a coating liquid containing at least one of a polyamic acid and a polyimine obtained as described above. In the case of the production example, the reaction solution of the polylysine or the polyimine may be directly or diluted, or the precipitate from the reaction solution may be redissolved in an organic solvent. Further, in the 'dilution or redissolution step', the solvent composition adjustment for controlling the coatability of the substrate or the addition of the additive for improving the film properties can be performed. Further, other resins which are mixed with a solution of a polyimine solution or a polyamic acid of a different structure as described above may be added. The organic solvent used in the above-mentioned dilution or redissolution step is not particularly limited as long as the polymer contained therein is dissolved. Specific examples thereof are N,N-dimethylformamide, hydrazine, hydrazine dimethylacetamide, N-methyl-2-pyrrolidone, -30-201132745 N-methyl caprolactam, 2 -pyrrolidone, N-ethyl-2-pyrrolidone, N-vinylpyrrolidone, dimethyl hydrazine, tetramethylurea, dimethyl hydrazine, hexamethylarylene, γ-butyrolactone, 1,3 - Dimethylimidazolidinone and the like. Among them, Ν-methyl-2-pyrrolidone, Ν-ethyl-2-pyrrolidone, l,3-dimethylimidazolidone, and γ-butyrolactone are suitable. These may be used alone or in combination of two or more. The solvent added to control the applicability of the liquid crystal alignment agent to the substrate is exemplified by ethyl cellosolve, butyl cellosolve, ethyl carbitol, butyl carbitol, ethyl carbitol acetate, and ethylene. Alcohol, b-methoxy-2-propanol ' 1-ethoxy-2-propanol, 1-butoxy-2-propanol, 1-phenoxy-2-propanol, diethylene glycol II Ethyl ether, propylene glycol monoacetate, propylene glycol diacetate, dipropylene glycol monomethyl ether, propylene glycol-1-monomethyl ether-2-acetate, propylene glycol-1-monoethyl ether-2-ethyl Acid ester, dipropylene glycol, 2-(2-ethoxypropoxy)propanol, methyl lactate, ethyl lactate, n-propyl lactate, n-butyl lactate, isoamyl lactate, and the like. The solvent may contain a solvent which does not dissolve polyphosphoric acid or polyimine alone, but may be mixed in the liquid crystal alignment agent of the present invention as long as it does not precipitate the polymer. In particular, by appropriately mixing a solvent having a low surface tension, the uniformity of the coating film at the time of coating the substrate can be improved, and it can also be suitably used in the liquid crystal alignment treatment agent of the present invention. Among them, in particular, from the viewpoint of solubility of polyimine, butyl cellosolve, ethyl carbitol, dipropylene glycol monomethyl ether, and diethylene glycol diethyl ether are preferable. Additives for improving film properties are exemplified by 3-aminopropylmethyldiethoxydecane, 3-phenylaminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, (Aminoethylaminomethyl) phenethyltrimethoxyindole-31 - 201132745 Alkane and other decane coupling agent. When the decane coupling agent is added, the adhesion of the coating film to the substrate can be improved. However, when the amount is too large, aggregation of polyamine or polyimine is likely to occur. Therefore, the content of the decane coupling agent is preferably from 0.5 to 10% by mass, more preferably from 1 to 5 % by mass, based on the total mass of the polyamic acid and the polyimine. The solid content concentration of the liquid crystal alignment agent of the present invention can be appropriately changed depending on the setting of the thickness of the liquid crystal alignment film to be formed, but is preferably from 1 to 10% by mass. When it is less than 1% by mass, it is difficult to form a uniform and defect-free coating film, and when it is more than 10% by mass, the solution storage stability may be deteriorated. The solid component referred to herein means a solvent which is removed from the liquid crystal alignment agent. Further, the concentration of the polyamic acid or the polyimine used in the liquid crystal alignment agent of the present invention is not particularly limited, but is preferably 1% by mass or more, more preferably from the viewpoint of the characteristics of the obtained liquid crystal alignment film. It is 3% by mass or more, preferably 5% by mass or more. The liquid crystal alignment treatment agent obtained above is preferably passed through a furnace before being applied to a substrate. <Liquid crystal display device> The liquid crystal alignment agent of the present invention can be applied onto a substrate, dried, and fired to form a coating film, and the coating film surface is rubbed and treated to be used as a liquid crystal alignment film for rubbing. Alternatively, it may be used as a VA (for vertical alignment) liquid crystal alignment film or a photo alignment film without rubbing treatment. In this case, the substrate to be used is not particularly limited as long as it is a substrate having high transparency, and a plastic substrate such as a glass substrate, an acrylic substrate or a polycarbonate substrate can be used, and a liquid crystal drive is used in view of simplification of the process. 32-201132745 It is preferable to use a substrate such as an ITO electrode. Further, the reflective liquid crystal display device may use an opaque material such as a germanium wafer only on a substrate on one side, and in this case, a material that reflects light such as aluminum may be used as the electrode. The coating method of the liquid crystal alignment treatment agent is exemplified by a spin coating method, a printing method, an inkjet method, etc., but in terms of productivity, a soft printing method is widely used in the industry, and is also suitable for the liquid crystal alignment treatment of the present invention. Agent. The drying step after the application of the liquid crystal alignment treatment agent is not necessarily required, but the drying step is preferably carried out when the time from the application of the coating to the time of firing is not necessarily performed for each of the substrates, or when it is not immediately fired after coating. Drying is preferred to evaporate the solvent to such an extent that the shape of the coating film is not deformed by the transport of the substrate, and the drying means is not particularly limited, and is, for example, a hot plate of 50 to 150 ° C, preferably 80 to 120 ° C. Dry for 0.5 to 30 minutes, preferably for 1 to 5 minutes. The firing of the substrate coated with the liquid crystal alignment agent is preferably carried out at any temperature of from 100 to 3 50 ° C, more preferably from 150 to 300 ° C, still more preferably from 18 0 to 250 ° C. When the proline group is present in the liquid crystal alignment agent, the conversion ratio of the conversion of the proline to the quinone is changed depending on the firing, but the liquid crystal alignment agent of the present invention does not necessarily need to be imidized by 100%. When the thickness of the coating film after firing is too thick, the power consumption of the liquid crystal display element is unfavorable. When the thickness of the liquid crystal display element is too small, the reliability of the liquid crystal display element is lowered, so that it is preferably from 10 to 200 nm, more preferably from 50 to 100 nm. As the above-described rubbing treatment of the coating film formed on the substrate, a conventional friction device can be used. The material of the rubbing cloth at this time is exemplified by cotton, enamel, nylon, etc. The substrate to which the liquid crystal alignment film is attached by the above-mentioned method can be produced by the method of the present invention, and the liquid crystal cell is produced as an example of the liquid crystal display element. Generally, a method of forming a liquid crystal alignment alcohol of 1 to 30 μm, more preferably 2 to 10 μm, and maintaining the direction of any angle of 〇2 to 27°, and sealing it with a dense liquid crystal is used. The method of encapsulating the liquid crystal is shown as a drop-in (ODF) method in which the liquid crystal is produced by intracellular pressure reduction, and then liquid crystal is injected. The liquid crystal display element thus obtained is used in various types of display elements such as 5, STN liquid crystal display elements, TFT liquid crystal display elements, and lateral electric field type (IPS) liquid crystal display elements. EXAMPLES Examples are given below, and the explanation is explained in more detail to be limited to these. (Synthesis Example 1) Synthesis of 3,5-diaminobenzyl benzoate in a 500 mL four-necked flask, 20.0 g of pyridine nitrobenzyl alcohol, 14.9 g of benzamidine chloride, in a solution at room temperature Stir for 30 hours. The reaction mixture was stirred for 1 hour. The organic hydrazine was extracted with ethyl acetate. The aqueous sodium hydrogencarbonate solution and the saturated aqueous sodium chloride solution were added to the organic layer to be dehydrated and dried, and filtered. If the liquid crystal cell is produced: one of the pair of substrates is preferably used so that the rubbing direction is fixed around the sealing agent, the injection is not particularly limited, and the vacuum method of the crystal can be exemplified, and the dropping liquid is used as the liquid crystal display element element, Ο C Β liquid crystal display R element, VA liquid crystal display invention, but the invention should not add 8.8g to the solution containing 3,5-ditetrahydrofuran 150mL, add pure water 50 m LI, 1N hydrochloric acid, saturated layer . Anhydrous magnesium sulfate was distilled off using a rotary evaporator at -34 - 201132745. The residue was recrystallized using ethyl acetate to synthesize 24.9 g of a dinitro compound having the following NMR characteristics (yield: 82%). 'H NMR (400 MHz, CDC13): δ 9.03 (t, 1H), 8.65 (d, 2H), 8.12-8.07 (m, 2H), 7.63 (tt, 1H), 7.5 3-7.47 (m, 2H) , 5.55 (s, 2H). [Chem. 17]
於500mL四頸燒瓶中添加二硝基化合物24.9g、鈾/碳 2.5g、1,4-二噁烷250g,在氫氣氛圍下於室溫攪拌。反應 結束後進行矽藻土過濾’使用旋轉蒸發器進行溶劑之飽除 。殘留物使用甲醇進行再結晶’合成12.8g之薄茶色固體 (收率6 4 % )。 該薄茶色固體以NMR測定之結果示於下。由該結果確 認所得薄茶色固體爲目的之二胺化合物。 丨 Η N M R (4 0 0 Μ H z,D M S Ο - d 6 ) : δ 8.0 1 - 7.9 9 (m,2 Η),7.6 9 7.64 (m, 1Η), 7.57-7.51 (m, 2H), 5.87 (d, 2H), 5.79 (t, 1H),5.06 (s, 2H),4.80 (br, 4H)。 [化 18]24.9 g of a dinitro compound, 2.5 g of uranium/carbon, and 250 g of 1,4-dioxane were placed in a 500 mL four-necked flask, and the mixture was stirred at room temperature under a hydrogen atmosphere. After the completion of the reaction, the diatomaceous earth was filtered. The solvent was purged using a rotary evaporator. The residue was recrystallized using methanol to synthesize 12.8 g of a thin brown solid (yield 64%). The results of the NMR measurement of the thin brown solid are shown below. From the results, it was confirmed that the obtained thin brown solid was the intended diamine compound. NMR NMR (4 0 0 Μ H z, DMS Ο - d 6 ) : δ 8.0 1 - 7.9 9 (m, 2 Η), 7.6 9 7.64 (m, 1 Η), 7.57-7.51 (m, 2H), 5.87 (d, 2H), 5.79 (t, 1H), 5.06 (s, 2H), 4.80 (br, 4H). [Chem. 18]
201132745 (合成例2 ) 菸鹼酸3, 5-二胺基苄基酯之合成 於500mL三頸燒瓶中添加1,3-二硝基苄基醇25.0g、吡 啶甲醯氯鹽酸鹽24.6g、N,N-二甲胺基吡啶1.4g、四氫呋 喃3 00mL。滴加三乙胺52.8mL,在室溫攪拌18小時。反應 結束後,添加純水50mL攪拌1小時。添加乙酸乙酯萃取有 機層,以1 N鹽酸、飽和碳酸氫鈉水溶液、飽和食鹽水洗 淨有機層。將無水硫酸鎂添加於有機層中脫水乾燥,經過 濾後,使用旋轉蒸發器進行溶劑之餾除。使用四氫呋喃/ 己烷=1/4使殘留物進行再結晶,合成36.0g之具有下述 NMR特性之二硝基化合物(收率94% )。 'H NMR (400 MHz,CDC13) : δ 9.04 (t, 1H), 8.83 -8.79 (m, 1H), 8.71-8.65 (m, 2H), 8.19 (dt, 1H), 7.91 (d, 1H), 7.59-7.54 (m,1H),5.64 (d,2H)。 [化 19]201132745 (Synthesis Example 2) Synthesis of 3, 5-diaminobenzyl nicotinic acid ester In a 500 mL three-necked flask, 25.0 g of 1,3-dinitrobenzyl alcohol and 24.6 g of pyridinium chloride hydrochloride were added. N, N-dimethylaminopyridine 1.4 g, tetrahydrofuran 300 mL. 52.8 mL of triethylamine was added dropwise, and the mixture was stirred at room temperature for 18 hours. After completion of the reaction, 50 mL of pure water was added and stirred for 1 hour. The organic layer was extracted with ethyl acetate, and the organic layer was washed with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and brine. Anhydrous magnesium sulfate was added to the organic layer to dehydrate and dry, and after filtration, the solvent was distilled off using a rotary evaporator. The residue was recrystallized using tetrahydrofuran / hexane = 1/4 to synthesize 36.0 g of a dinitro compound having the following NMR characteristics (yield: 94%). 'H NMR (400 MHz, CDC13): δ 9.04 (t, 1H), 8.83 -8.79 (m, 1H), 8.71-8.65 (m, 2H), 8.19 (dt, 1H), 7.91 (d, 1H), 7.59-7.54 (m, 1H), 5.64 (d, 2H). [Chem. 19]
於5 00mL四頸燒瓶中添加二硝基化合物29.4g、鈿/碳 4.5 g、1,4 -二噁烷4 3 0 g,在氫氣氛圍下於室溫攪拌。反應 結束後進行矽藻土過濾,使用旋轉蒸發器進行溶劑之餾除 。殘留物使用異丙醇進行再結晶,合成20.2g之薄茶色固 體(收率86%)。 -36- 201132745 該薄茶色固體以NMR測定之結果示於下。由該結果確 認所得薄茶色固體爲目的之二胺化合物。 'H NMR (400 MHz,CDC13) : δ 8.80-8.76 (m, 1 Η), 8.14 (dt, 1H), 7.83 (dt, 1H), 7.50-7.45 (m, 1H), 6.23 (d, 2H), 6.00 (t,1H),5.28 (s,2H), 3.1 (br,4H)。 [化 20]To a 500 mL four-necked flask, 29.4 g of a dinitro compound, 4.5 g of ruthenium/carbon, and 430 g of 1,4-dioxane were added, and the mixture was stirred at room temperature under a hydrogen atmosphere. After the completion of the reaction, the diatomaceous earth was filtered, and the solvent was distilled off using a rotary evaporator. The residue was recrystallized using isopropyl alcohol to synthesize 20.2 g of a thin brown solid (yield 86%). -36- 201132745 The result of the NMR measurement of the thin brown solid is shown below. From the results, it was confirmed that the obtained thin brown solid was the intended diamine compound. 'H NMR (400 MHz, CDC13): δ 8.80-8.76 (m, 1 Η), 8.14 (dt, 1H), 7.83 (dt, 1H), 7.50-7.45 (m, 1H), 6.23 (d, 2H) , 6.00 (t, 1H), 5.28 (s, 2H), 3.1 (br, 4H). [Chem. 20]
(合成例3 ) 3,5-二胺基苄基-1,3,4_三甲基吡唑-5-羧酸酯之合成 於5 00mL四頸燒瓶中添加1,3,4-三甲基-1H-吡唑-5-羧 酸17.1g、二氯甲烷250mL,冷卻至溫度0度。添加草醯二 氯10.2mL、DMF0.8g,在室溫攪拌2小時。攪拌後添加3,5-二硝基苄基醇22.0g、吡啶9.7g,在室溫攪拌41小時。反 應結束後,添加純水50mL攪拌1小時。添加乙酸乙酯萃取 有機層,且以1N鹽酸、飽和碳酸氫鈉水溶液、飽和食鹽 水洗淨有機層。將無水硫酸鎂添加於有機層中脫水乾燥, 經過濾後,使用旋轉蒸發器進行溶劑之餾除。使用異丙醇 使殘留物進行再結晶,獲得1 8 . 1 g之具有下述NMR特性之 二硝基化合物(收率7 1 % )。 'H NMR (400 MHz, CDC13) : δ 9.04 (t, 1H),8.64 (dt, 2H), 5.54 (t, 2H), 4.08 (s, 3H), 2.24 (s, 3H), 2.21 (s, 3H) -37- 201132745 [化 21](Synthesis Example 3) Synthesis of 3,5-diaminobenzyl-1,3,4-trimethylpyrazole-5-carboxylate Addition of 1,3,4-trimethyl to a 500 mL four-necked flask 17.1 g of benzyl-1H-pyrazole-5-carboxylic acid and 250 mL of dichloromethane were cooled to a temperature of 0 degree. 10.2 mL of grass dichloride, 0.8 g of DMF was added, and the mixture was stirred at room temperature for 2 hours. After stirring, 22.0 g of 3,5-dinitrobenzyl alcohol and 9.7 g of pyridine were added, and the mixture was stirred at room temperature for 41 hours. After the reaction was completed, 50 mL of pure water was added and stirred for 1 hour. The organic layer was extracted with ethyl acetate, and the organic layer was washed with 1N hydrochloric acid, saturated aqueous sodium hydrogen carbonate and brine. Anhydrous magnesium sulfate was added to the organic layer to dehydrate and dry, and after filtration, the solvent was distilled off using a rotary evaporator. The residue was recrystallized using isopropyl alcohol to obtain 18.1 g of a dinitro compound having the following NMR characteristics (yield 71%). 'H NMR (400 MHz, CDC13): δ 9.04 (t, 1H), 8.64 (dt, 2H), 5.54 (t, 2H), 4.08 (s, 3H), 2.24 (s, 3H), 2.21 (s, 3H) -37- 201132745 [Chem. 21]
於5 00mL四頸燒瓶中添加二硝基化合物l8.〇g、鉑/碳 1.8g、四氫呋喃180g,在氫氣氛圍下攪拌I7小時。反應結 束後進行矽藻土過濾,使用旋轉蒸發器進行溶齊11 = ° 殘留物使用四氫呋喃與異丙醇進行再結晶’獲得9.8g= _ 茶色固體(收率67% )。 該薄茶色固體以NMR測定之結果示於下。由該結果® 認所得薄茶色固體爲目的之二胺化合物。 1 Η) 'Η NMR (400 MHz, CDC13) : δ 6.15 (d, 2H), 5.98 (t, 5.15 (s,2H), 4.06 (s,3H),3.58 (br,4H),2.18 (s,6H) 0 [化 22]A dinitro compound 18.8 g, platinum/carbon 1.8 g, and tetrahydrofuran (180 g) were added to a 500 mL four-necked flask, and the mixture was stirred under a hydrogen atmosphere for 1 hour. After completion of the reaction, the mixture was filtered through Celite, and then evaporated on a rotary evaporator. <RTI ID=0.0>>> The results of the NMR measurement of the thin brown solid are shown below. The result is a diamine compound for the purpose of obtaining a thin brown solid. 1 Η) 'Η NMR (400 MHz, CDC13) : δ 6.15 (d, 2H), 5.98 (t, 5.15 (s, 2H), 4.06 (s, 3H), 3.58 (br, 4H), 2.18 (s, 6H) 0 [Chem. 22]
(合成例4 ) 苯甲酸2-(吡啶-2-基)乙基-3,5-二胺基酯之合成 於3 00mL四頸燒瓶中,將2-吡啶乙醇23.4 5 g、三乙胺 19.23g溶解於四氫呋喃200mL中,冷卻至10°C以下’邊注 -38- 201132745 意發熱邊滴加將二硝基苯甲醯氯41.68g溶解於四氫咲喃 ll〇g中而成之溶液。滴加結束後,反應溫度上升至23〇c, 再進行反應。確認反應結束後,將反應液倒入蒸餾水丨.5 L 中,過濾析出之固體,經水洗後,以乙醇3 8 0 g進行分散洗 淨’獲得50.82g之具有下述NMR特性之二硝基化合物(收 率:8 9 % )。 1HNMR (400MHz,DMSO-d6) : δ 9.76 (t, 1 Η) 9.09-9.02 (m,2H),8.99-8.93 (m,lH),8.50 (m,lH),7.64-7.60 (m,iH), 7.3 6-7.3 2 (m,lH),4.57 (s,2H),3.35 (s,2H)» [化 23](Synthesis Example 4) Synthesis of 2-(pyridin-2-yl)ethyl-3,5-diaminoester benzoate in a 300 mL four-necked flask, 2-pyridine ethanol 23.4 5 g, triethylamine 19.23 g is dissolved in 200 mL of tetrahydrofuran, and cooled to 10 ° C or less. 'Bian-38-201132745 A solution obtained by dissolving 41.68 g of dinitrobenzhydryl chloride in tetrahydrofuran 〇 〇g was added dropwise. After the completion of the dropwise addition, the reaction temperature was raised to 23 ° C, and the reaction was further carried out. After confirming the completion of the reaction, the reaction solution was poured into 1.5 L of distilled water, and the precipitated solid was filtered, washed with water, and then washed with ethanol 380 g to obtain 50.82 g of dinitro group having the following NMR characteristics. Compound (yield: 89%). 1HNMR (400MHz, DMSO-d6) : δ 9.76 (t, 1 Η) 9.09-9.02 (m, 2H), 8.99-8.93 (m, lH), 8.50 (m, lH), 7.64-7.60 (m, iH) , 7.3 6-7.3 2 (m, lH), 4.57 (s, 2H), 3.35 (s, 2H)» [Chem. 23]
在氫氣氛圍下以23 °C攪拌二硝基化合物4 8.00g、鉑碳 4.8g、1,4-二噁烷490g之混合物。反應結束後,以矽藻土 過濾觸媒後,以蒸發器餾除溶劑獲得粗製產物。以乙醇 3 00 g分散洗淨粗製產物,獲得具有下述NMR特性之目的二 胺化合物(產量:27.20g,產率:70%)。 'HNMR (400MHz,DMSO-d6) : 5 8.64 (t, 1 Η), 8.44 (d, 1 Η), 7.67 (d,lH), 7_34 (q,lH),6.23 (d,2H),5·94 (S,1H),4.87 (b,4H),4.39 (d,2H),3.38 (s,2H)。 -39 - 201132745 [化 24]A mixture of 48.00 g of a dinitro compound, 4.8 g of platinum carbon, and 490 g of 1,4-dioxane was stirred at 23 ° C under a hydrogen atmosphere. After completion of the reaction, the catalyst was filtered with diatomaceous earth, and then the solvent was distilled off with an evaporator to obtain a crude product. The crude product was washed away by dispersing ethanol (300 g) to obtain the objective diamine compound (yield: 27.20 g, yield: 70%). 'HNMR (400MHz, DMSO-d6): 5 8.64 (t, 1 Η), 8.44 (d, 1 Η), 7.67 (d,lH), 7_34 (q,lH), 6.23 (d,2H),5· 94 (S, 1H), 4.87 (b, 4H), 4.39 (d, 2H), 3.38 (s, 2H). -39 - 201132745 [Chem. 24]
1,4-二噁烷 60°C H2N1,4-dioxane 60°C H2N
實施例卜10及比較例1~4 下述實施例1〜1 0及比較例1〜4中,雖記載液晶配向處 理劑之製造例,但聚醯胺酸及聚醯亞胺之合成所使用之簡 寫說明如下述,且,有關 <分子量之測定 >、<醯亞胺化率 之測定 >、<摩擦耐性之評價 >、<液晶胞之製作 >、<預傾 角之評價 >、<電壓維持率之測定方法 >、及 <累積電荷( RDC)之評價 >之方法如下述。 再者該等實施例及比較例之各液晶配向處理劑之物性 (特性)彙整示於後述之表1及表2。 〈四羧酸二酐〉 CBDA : 1,2,3,4-環丁烷四羧酸二酐 〈二胺〉 DABPh:苯甲酸3,5-二胺基苄基酯 0八8卩丫:菸鹼酸3,5-二胺基苄基酯 DABTMPz: 3,5-二胺基节基-1,3,4-三甲基-1H-0比唑- 5- 羧酸酯 1^[0八:3,5-二胺基苯甲酸2-(吡啶.2-基)乙酯 C14DAB: 4 -十四烷氧基-1,3 -二胺基苯 3-ABA : 3-胺基苄基胺 -40- 201132745 〈有機溶劑〉 NMP : N-甲基-2-吡咯烷酮 γΒί : γ-丁內醋 B C : 丁基溶纖素 DPM :二丙二醇單甲基醚 〈分子量之測定〉 聚醯胺酸及聚醯亞胺之分子量係利用下述之Gpc (常 溫凝膠滲透層析儀)裝置測定該聚醯亞胺,且爲聚乙二醇 及聚環氧乙烷換算値,分別算出數平均分子量及重量平均 分子量。 GPC裝置:Shodex公司製造(GPC-101) 管柱:Shodex公司製造(KD803、KD805串聯)Example 10 and Comparative Examples 1 to 4 In the following Examples 1 to 10 and Comparative Examples 1 to 4, the production examples of the liquid crystal alignment treatment agent were described, but the synthesis of polyacrylic acid and polyimine was used. The following is a description of <measurement of molecular weight>, <measurement of yttrium imidation rate>, <evaluation of friction resistance>, <production of liquid crystal cell>> The method of evaluating the inclination angle >, <measurement method of voltage maintenance rate>, and <evaluation of accumulated electric charge (RDC)> is as follows. Further, the physical properties (characteristics) of the respective liquid crystal alignment treatment agents of the examples and the comparative examples are shown in Tables 1 and 2 which will be described later. <tetracarboxylic dianhydride> CBDA : 1,2,3,4-cyclobutane tetracarboxylic dianhydride <diamine> DABPh: 3,5-diaminobenzyl benzoate 0 8 8: smoke Alkaline acid 3,5-diaminobenzyl DABTMPz: 3,5-diamino-based 1,3,4-trimethyl-1H-0-pyrazole-5-carboxylate 1^[0 : 2,5-diaminobenzoic acid 2-(pyridine.2-yl)ethyl ester C14DAB: 4-tetradecyloxy-1,3-diaminobenzene 3-ABA: 3-aminobenzylamine -40- 201132745 <Organic solvent> NMP : N-methyl-2-pyrrolidone γ Β : γ-butyrolactone BC : butyl cellosolve DPM : dipropylene glycol monomethyl ether <Determination of molecular weight> Polylysine and polypeptone The molecular weight of the imine is measured by the Gpc (normal temperature gel permeation chromatography) apparatus described below, and the number average molecular weight and the weight average are calculated by converting polyethylene glycol and polyethylene oxide. Molecular weight. GPC device: manufactured by Shodex (GPC-101) Pipe column: manufactured by Shodex (KD803, KD805 series)
管柱溫度:5 0 °C 溶離液:N,N-二甲基甲醯胺(作爲添加劑,溴化鋰單 水合物(LiBr.H20)爲30mmol/L,磷酸.無水結晶(〇_ 磷酸)爲30mmol/L,四氫呋喃(THF)爲10mI/L) 流速:1 .OmL/分鐘 校正線作成用之標準樣品:TOSHO公司製造 TSK 標準聚環氧乙烷(數平均分子量約900,000、1 5 0,000、 1 00,000、3 0,0 00 ),及 Polymer Laboratories公司製造之 聚乙二醇(重量平均分子量約丨2,〇〇〇、4,000、1,000)。 -41 - 201132745 〈醯亞胺化率之測定〉 聚醯亞胺之醯亞胺化率係將該聚醯亞胺溶解於d6-DMSO (二甲基亞颯- d6)中,測定1H-NMR,由質子峰之 累積値之比求得未醯亞胺化而殘留之醯胺酸基之比率而算 出》 〈摩擦耐性之評價〉 將各液晶配向處理劑旋轉塗佈於貼附透明電極之玻璃 基板上,在8(TC之加熱板上乾燥5分鐘後,在210°C之加熱 板上進行燒成10分鐘,形成膜厚70nm之塗膜。以輥直徑 120mm之摩擦裝置(飯沼Gauge製作所製作 RS01-2型) ,使用嫘縈布,以輥轉數lOOOrpm,輥進行速度50mm/sec ,擠入量0.5 mm之條件摩擦該塗膜面,獲得貼附液晶配向 膜之基板。以共焦雷射顯微鏡觀察液晶配向膜表面。評價 係依據下列基準表示。 〇:未觀察到削渣或摩擦傷痕 △:觀察到削渣或摩擦傷痕 X :膜剝離或以目視觀察到摩擦傷痕 〈液晶胞之製作〉 使用各液晶配向處理劑,如下列製作液晶胞。 將各液晶配向處理劑旋轉塗佈於貼附透明電極之玻璃 基板上,在80°C之加熱板上乾燥5分鐘後,在210°C之加熱 板上進行燒成1〇分鐘’形成膜厚70nm之塗膜。以輥直徑 -42- 201132745 120mm之摩擦裝置,使用嫘縈布,以輥轉數i〇〇〇rpm,輥 進行速度50mm/sec,擠入量〇.3mm之條件摩擦該塗膜面, 獲得貼附液晶配向膜之基板。準備兩片貼附液晶配向膜之 基板,於其一片之液晶配向膜面上散布6μιη之隔離物後, 自其上印刷密封劑,且使另一片基板以使液晶配向膜面對 向且摩擦方向成垂直之方式貼合後,使密封劑硬化製作空 胞。利用減壓注入法於該空胞內注入液晶M L C - 2 0 0 3 (日 本Merck公司製造),封閉注入口,獲得扭轉向列型( T w i s t e d N e m a t i c )液晶胞。 〈預傾角之測定〉 在1 〇 5 t下加熱以上述〈液晶胞製作〉中所述之方法 製作扭轉向列型液晶胞5分鐘後,進行預傾角之測定及電 壓維持率之測定。預傾角係使用結晶旋轉法測定。 〈電壓維持率之測定〉 對以上述〈液晶胞製作〉中所述之方法製作之扭轉向 列型液晶胞在90°C之溫度下施加4V電壓60μδ,且測定 16·67ms後之電壓,求得能維持多少電壓等作爲電壓維持 率。再者,電壓維持率之測定係使用電壓維持率測定裝置 (東陽科技公司製造,VHR-1)。 〈累積電荷(RDC )之評價〉 對以上述〈液晶胞製作〉中所述之方法製作之扭轉向 -43- 201132745 列型液晶胞,在2 3 °C之溫度下,以0.1 V間隔自〇V施加直流 電壓至1.0V,測定各電壓下之閃爍振幅(Flicker amplitude)位準,作成校正線。接著,接地5分鐘後,施 加交流電壓3.0V,直流電壓5.0V,測定1小時後之閃爍振 幅位準,且藉由與預先製作之校正線比對評價RDC。該 RDC之評價方法稱爲閃爍參照法。 (實施例1 ) 使用5.00g ( 25mmol )之CBDA作爲四羧酸二酐成分、 6.30g(26mmol)之 DABPh 作爲二胺成分,在 NMP 45.18g 中,於室溫反應16小時,獲得20質量%之聚醯胺酸溶液( PAA-1 )。 使用NMP 13.3g及BC l〇.〇g稀釋該聚醯胺酸溶液( PAA-1) 10.0g,獲得由含有6質量%固體成分、64質量 %NMP及30質量%BC之溶液組成之液晶配向處理劑。 (實施例2 ) 將93.33g之NMP添加於實施例1獲得之聚醯胺酸溶液 (PAA-1濃度20質量%) 40g中加以稀釋,接著添加乙酸酐 5.64g及吡啶2.33g,在4(TC反應3小時進行醯亞胺化。使該 反應溶液冷卻至室溫左右後,倒入甲醇5 0 0 m L中,回收沉 澱之固形物。接著,以甲醇洗淨該固形物數次後,以 l〇〇°C減壓乾燥,獲得聚醯亞胺(SPI-1)之白色粉末。該 聚醯亞胺之數平均分子量爲14,630,重量平均分子量爲 -44- 201132745 3 2,1 6 0。又’醯亞胺化率爲8 2 % ° 將18.0g之γ-BL添加於所得之聚醯亞胺(SPI-1) 2.00g 中,以5(TC攪拌2〇小時。在攪拌結束之時點聚醯亞胺完全 溶解。接著於該溶液中添加8.0g之γ-BL、6.00g之BC及 6.00g之DPM,在50°C攪拌20小時’獲得由含有5質量·^。之 聚醯亞胺(SPI-1) 、65質量15質量%2DPM及 1 5質量%之B C之溶液組成之液晶配向處理劑。 (實施例3 ) 使用5.00g(25mmol)之CBDA作爲四殘酸二酉:l:成分、 6,32g ( 26mmol )之 DABPy作爲二胺成分,在 NMP 45_29g 中,於室溫反應1 6小時’獲得2 0質量%之聚醯胺酸溶液( PAA-2)。 使用NMP 13.3g及BC lO.Og稀釋該聚醯胺酸溶液( PAA-2 ) 10.〇g,獲得由含有6質量%固體成分、64質量 %NMP及30質量%BC之溶液組成之液晶配向處理劑。 (實施例4 ) 將93.3 3 g之NMP添加於實施例3獲得之聚醯胺酸溶液 (PAA-2濃度20質量%) 40g中加以稀釋,接著添加乙酸酐 5.77g及吡啶2.39g,在40°C反應3小時進行醯亞胺化。使該 反應溶液冷卻至室溫左右後,倒入甲醇500mL中,回收沉 澱之固形物。接著,以甲醇洗淨該固形物數次後,以 100°C減壓乾燥’獲得聚醯亞胺(SPI-2)之白色粉末。該 -45- 201132745 聚醯亞胺之數平均分子量爲13,204’重量平均分子量爲 30,700。又,醯亞胺化率爲87 %。 將18.0g之γ-BL添加於所得之聚醯亞胺(SPI-2) 2.00g 中,於5 0 °C攪拌2 0小時。在攪拌結束之時點聚醯亞胺完全 溶解。接著於該溶液中添加8.0g之γ-BL、6.00g之BC及 6.00g之DPM,在50°C攪拌20小時’獲得由含有5質量%之 聚醯亞胺(SPI-2) 、65質量%之γ-BL、15質量%2DPM及 1 5質量%之B C之溶液組成之液晶配向處理劑。 (實施例5 ) 使用5.30g(27mmol)之CBDA作爲四羧酸二酐成分、 2.00g ( 8mmol )之 DABPh、1 . 3 5 g ( 1 1 mmol )之 3-ABA 及 2.65g ( 8mmol)之 C14DAB 作爲二胺成分,在 NMP 45.25g 中,於室溫反應16小時’獲得20質量°/。之聚醯胺酸溶液( PAA-3 )。 使用NMP 13.3g及BC 10.0g稀釋該聚醯胺酸溶液( PAA-3 ) 10.0g,獲得由含有6質量。/。固形物、64質量%NMP 及30質量%BC之溶液組成之液晶配向處理劑。 (實施例6 ) 將9 3.3 3 g之NMP添加於實施例5獲得之聚醯胺酸溶液 (PAA-3濃度20質M%) 40g中加以稀釋,接著添加乙酸酐 5.97g及吡啶2.47g ’在60°C反應3小時進行醯亞胺化。使該 反應溶液冷卻至室溫左右後’倒入甲醇5 0 0 m L中’回收沉 -46- 201132745 澱之固形物。接著’以甲醇洗淨該固形物數次後’在 l〇(TC減壓乾燥,獲得聚醯亞胺(SPI-3 )之乳白色粉末。 該聚醯亞胺之數平均分子量爲14,785 ’重量平均分子量爲 3 7,4 8 3。又,醯亞胺化率.爲8 8 %。 將18.0g之γ-BL添加於所得之聚醯亞胺(SPI-3) 2.00g 中,在50°C攬拌20小時。在攪拌結束之時點聚醯亞胺完全 溶解。接著於該溶液中添加8.0g之γ-BL、6.00g之BC及 6.00g之DPM,在50°C攪拌2〇小時’獲得由含有5質量之聚 醯亞胺(SPI-3) 、65質量%之丫-8!^、15質量%之DPM及15 質量%之B C之溶液組成之液晶配向處理劑。 (實施例7 ) 使用5.27g(27mmol)之CBDA作爲四羧酸二酐成分、 2.00g ( 8mmol )之 DABPy、1.34g ( llmmol)之 3-ABA 及 2.63g(8mmol)之 C14DAB 作爲二胺成分,在 NMP 44.96g 中,於室溫反應1 6小時’獲得2 0質量%之聚醯胺酸溶液( PAA-4 )。 使用NMP 13.3g及BClO.Og稀釋該聚醯胺酸溶液( PAA-4 ) lO.Og,獲得由含有6質量%固體成分' 64質量 %NMP及3 0質量%BC之溶液組成之液晶配向處理劑。 (實施例8 ) 將9 3.3 3g之NMP添加於實施例7獲得之聚醯胺酸溶液 (PAA-4濃度20質量% ) 40g中加以稀釋,接著添加乙酸酐 -47- 201132745 5.97g及吡啶2.47g,在60°C反應3小時進行醯亞胺化。使該 反應溶液冷卻至室溫左右後,倒入甲醇5 0 0 m L中,回收沉 澱之固形物。接著,以甲醇洗淨該固形物數次後,以 l〇〇°C減壓乾燥,獲得聚醯亞胺(SPI-4 )之乳白色粉末。 該聚醯亞胺之數平均分子量爲15,5 94,重量平均分子量爲 4 2,3 2 0 ’又醯亞胺化率爲8 7 %。 將18.0g之γ-BL添加於所得之聚醯亞胺(SPI-4) 2.00g 中,在50°C攪拌20小時。在擞拌結束之時點聚醯亞胺完全 溶解。接著於該溶液中添加8.0g之γ-BL、6.00g之BC及 6.00g之DPM,在50°C攪拌20小時,獲得由含有5質量%之 聚醯亞胺(SPI-4 ) 、65質量%之γ-BL、15質量%之DPM及 15質量%之BC之溶液組成之液晶配向處理劑。 (實施例9 ) 使用5.57g(29mmol)之CBDA作爲四竣酸二酌1成分、 2_38g(9mmol)之 DABTMPz、1.4 2 g ( 1 2 m m ο 1 )之 3-ABA 及2.79g ( 9mmoI )之C 1 4DAB作爲二胺成分,在NΜP 46.7g中,於室溫反應16小時,獲得濃度20質量%之聚醯胺 酸溶液(PAA-5 )。 使用NMP 13.3g及BC 10.〇g稀釋該聚醯胺酸溶液( PAA-5 ) lO.Og,獲得由含有6質量%聚醯胺酸(PAA-5) 、 64質量%NMP及30質量%BC之溶液組成之液晶配向處理劑 -48- 201132745 (實施例1 〇) 將93.3 g之NMP添加於與實施例9同樣獲得之聚醯胺酸 (PAA-5 )溶液(PAA-5濃度20質量% ) 40.0g中加以稀釋 ,添加乙酸酐6.0 6 g及吡啶2 · 5 3 g,在6 (TC反應3小時進行醯 亞胺化。使該反應溶液冷卻至室溫左右後,倒入甲醇 500mL中,回收沉澱之固形物。接著,以甲醇洗淨該固形 物二次後,以100°C減壓乾燥,獲得聚醯亞胺(SPI-5)之 白茶色粉末。該聚醯亞胺之數平均分子量爲14,222,重量 平均分子量爲33,154。又,醯亞胺化率爲88 %。 將18.0g之γ-BL添加於所得之聚醯亞胺(SPI-5) 2.00g 中,在50°C攪拌20小時。在攪拌結束之時點聚醯亞胺完全 溶解。接著於該溶液中添加8.00g之γ-BL、6.00g之BC及 6.00g之DPM,在50°C攪拌20小時,獲得由含有5質量%之 聚醯亞胺(SPI-5) 、65質量%之γ-BL、15質量°/〇之DPM及 1 5質量%之B C之溶液組成之液晶配向處理劑。 (比較例1 ) 使用12.5g(64mmol)之CBDA作爲四羧酸二酐成分、 5.56g ( 46mmol )之 3 - A B A 及 6 · 2 5 g ( 2 0 m m ο 1 )之 C14DAB 作爲二胺成分,在NMP 97.20g中’於室溫反應16小時’獲 得20質量。/〇之聚醯胺酸溶液(PAA-6) ° 使用NMP 13.3g及BC lO.Og稀釋該聚醯胺酸溶液( PAA-6) 10.0g,獲得由含有6質量%固形物、64質量%NMP 及3 0質量% B C之溶液組成之液晶配向處理劑。 -49 - 201132745 (比較例2 ) 將1 16.67g之NMP添加於比較例1獲得之聚醯胺酸溶液 (PAA-6 ) 5 0g中加以稀釋,添加乙酸酐7.39g及吡啶3.15g ,在70°C反應3小時進行醯亞胺化,但反應中膠凝化。 再次,將116.67g之NMP添加於聚醯胺酸溶液(PAA-6 )50g中加以稀釋,添加乙酸酐7.39g及吡啶3.15g,在醯 亞胺化之溫度爲50°C進行。 使該反應溶液冷卻至室溫左右後,倒入甲醇600m L中 ,回收沉澱之固形物。接著,以甲醇洗淨該固形物數次後 ,在l〇〇°C減壓乾燥,獲得聚醯亞胺(SPI-6)之白色粉末 。該聚醯亞胺之數平均分子量爲16,338,重量平均分子量 爲3 9,86 5。又醯亞胺化率爲80%。 將9g之γ-BL添加於聚醯亞胺(SPI-6 )】.〇〇g中,在 5 0°C攪拌20小時。在攪拌結束之時點聚醯亞胺完全溶解。 接著於該溶液中添加4.0g之γ-BL、3.0g之BC及3.0g之DPM ,在50t攪拌20小時,獲得由含有5質量%之聚醯亞胺、65 質量%之γ - B L、1 5質量%之D P Μ及1 5質量%之B C之溶液組 成之液晶配向處理劑。 (比較例3 ) 使用5.76g(29mmol)之CBDA作爲四羧酸二酐成分、 2.31g(9mmol)之 RefDA、1.46g(12mmol)之 3_ABA 及 2.88g(9mmol)之 C14DAB 作爲二胺成分’在 NMP 56.84g -50- 201132745 中,於室溫反應1 6小時,獲得2 0質量%之聚醯胺酸溶液( PAA-7 )。 使用NMP 13.3g及BC lO.Og稀釋該聚醯胺酸溶液( PAA-7 ) 1 O.Og,獲得由含有6質量%固形物、64質量%NMP 及30質量%BC之溶液組成之液晶配向處理劑。 (比較例4 ) 將1 1 6 · 6 7 g之Ν Μ P添加於比較例3獲得之聚醯胺酸溶液 (PAA-7) 50g中力口以稀釋,添力Q乙酸酐7.39g及吡啶3.06g ,在70°C反應3小時進行醯亞胺化。 使該反應溶液冷卻至室溫左右後,倒入甲醇600mL中 ,回收沉澱之固形物。接著,以甲醇洗淨該固形物數次後 ,在l〇(TC減壓乾燥,獲得聚醯亞胺(SPI-7 )之薄茶色粉 末。該聚醯亞胺之數平均分子量爲18,668,重量平均分子 量爲41,256。又醯亞胺化率爲89 %。 將9g之γ-BL添加於聚醯亞胺(SPI-7 ) l.〇〇g中’在 5 (TC攪拌20小時。在攪拌結束之時點聚醯亞胺完全溶解。 接著於該溶液中添加4.0g之γ-BL、3.0g之BC及3.0g之DPM ,在50°C攪拌20小時,獲得由含有5質量%之聚醯亞胺、65 質量%之γ - B L、1 5質量%之D P Μ及1 5質量%之B C之溶液組 成之液晶配向處理劑。 [產業上之可能利用性] 藉由本發明之液晶配向處理劑,可獲得在摩擦時之膜 -51 - 201132745 剝離或削減較強,電壓維持率高,且即使施加直流電壓亦 難以引起初期電荷累積之液晶配向膜。據此,使用本發明 之液晶配向處理劑製作之液晶顯示元件可成爲信賴性高之 液晶顯示裝置,適用於TN液晶顯示元件、STN液晶顯示元 件、TFT液晶顯示元件、VA液晶顯示元件、IPS液晶顯示 元件、OCB液晶顯示元件等利用各種方式之顯示元件。 m 1] 聚醯胺酸 溶液或聚 醯亞胺 醯亞胺 化率 [%] 二酸酐成分 (mmol) 二胺成分 (mmol) 固體 成分 (%) 實施例1 PAA-1 CBDA(25) DABPh(26) 6.0 實施例2 SPI-1 82 CBDA(25) DABPh(26) 5.0 實施例3 PAA-2 - CBDA(25) DABPy(26) 6.0 實施例4 SPI-2 87 CBDA(25) DABP 火 26) 5.0 實施例5 PAA-3 - CBDA(27) 3-ABA(ll),DABPh(8), C14DAB(8) 6.0 實施例6 SPI-3 88 CBDA(27) 3-ABA(ll),DABPh(8), C14DAB(8) 5.0 實施例7 PAA-4 - CBDA(27) 3-ABA(l l),DABPy(8), C14DAB(8) 6.0 實施例8 SPI-4 87 CBDA(27) 3-ABA(ll),DABPy(8), C14DAB(8) 5.0 實施例9 PAA-5 - CBDA(29) 3-ABA(12),DABTMPz(9) C14DAB(9) 6.0 實施例10 SPI-5 88 CBDA(29) 3-ABA(12),DABTMPz(9) C14DAB(9) 5.0 比較例1 PAA-6 - CBDA(64) 3-ABA(46),C14DAB(20) 6.0 比較例2 SPI-6 80 CBDA(64) 3-ABA(46),C14DAB(20) 5.0 比較例3 PAA-7 - CBDA(29) 3-ABA(12),RefDA(9), C14DAB(9) 6.0 比較例4 SPI-7 89 CBDA(29) 3-ABA(12),RefDA (9), C14DAB(9) 5.0 -52- 201132745 [表2] 摩擦耐性 傾角[。] 電壓維持率[%]90°〇 RDCm 實施例1 〇 0.7 90 0.24 實施例2 〇 0.8 92 0.20 實施例3 〇 1.0 92 0.23 實施例4 〇 1.2 93 0.17 實施例5 〇 6.1 92 0.25 實施例6 〇 3.1 94 0.21 實施例7 〇 5.1 93 0.20 實施例8 〇 3.4 95 0.16 實施例9 〇 5.7 93 0.21 實施例10 〇 3.7 95 0.15 比較例1 Δ 4.5 87 0.50 比較例2 X 3.1 92 0.45 比較例3 Δ 4.7 90 0.30 比較例4 Δ 3.3 92 0.25 又,本文中援用2009年12月14日申請之日本專利申請 案200 9-2 8 3 3 3 0號之說明書、申請專利範圍及摘要之全部 內容,且納入作爲本發明說明書之揭示。 -53-Column temperature: 50 °C Dissolution: N,N-dimethylformamide (as an additive, lithium bromide monohydrate (LiBr.H20) is 30 mmol/L, phosphoric acid. Anhydrous crystal (〇_phosphoric acid) is 30 mmol /L, tetrahydrofuran (THF) is 10mI / L) Flow rate: 1.0 mL / min calibration line standard sample for production: TSK standard polyethylene oxide manufactured by TOSHO company (number average molecular weight of about 900,000, 1 500,000, 1 00,000 , 30,0 00 ), and polyethylene glycol (weight average molecular weight of about 〇〇〇2, 〇〇〇, 4,000, 1,000) manufactured by Polymer Laboratories. -41 - 201132745 <Determination of the imidization rate of oxime> The imidization ratio of polyimine is dissolved in d6-DMSO (dimethyl sulfonium-d6), and 1H-NMR is measured. Calculated by the ratio of the cumulative enthalpy of the proton peak to the ratio of the proline group remaining without imidization. <Evaluation of friction resistance> Each liquid crystal alignment treatment agent was spin-coated on a glass substrate to which a transparent electrode was attached. After drying on a hot plate of 8 (TC) for 5 minutes, it was baked on a hot plate at 210 ° C for 10 minutes to form a coating film having a film thickness of 70 nm. A friction device having a roll diameter of 120 mm (RS01 manufactured by Iijima Gauge Co., Ltd.) -2 type), using a crepe cloth, rubbing the surface of the film with a roller rotation number of 100 rpm, a roller speed of 50 mm/sec, and a pushing amount of 0.5 mm to obtain a substrate to which a liquid crystal alignment film is attached. The surface of the liquid crystal alignment film was observed. The evaluation was based on the following criteria: 〇: no slag or friction scar was observed Δ: slag or friction scar was observed X: film peeling or visual observation of friction scars <production of liquid crystal cells> Each liquid crystal alignment treatment agent is produced as follows Liquid crystal cells. Each liquid crystal alignment treatment agent was spin-coated on a glass substrate to which a transparent electrode was attached, and dried on a hot plate at 80 ° C for 5 minutes, and then fired on a hot plate at 210 ° C for 1 minute. A coating film having a film thickness of 70 nm was formed, and a rubbing device having a roll diameter of -42 - 201132745 120 mm was used, and a crepe cloth was used, and the number of rolls was i rpm, the speed of the roll was 50 mm/sec, and the amount of squeezing was 3 mm. Rubbing the surface of the coating film to obtain a substrate to which the liquid crystal alignment film is attached. Two substrates to which the liquid crystal alignment film is attached are prepared, and a spacer of 6 μm is spread on one of the liquid crystal alignment film faces, and a sealant is printed thereon, and After the other substrate is bonded such that the liquid crystal alignment film faces and the rubbing direction is perpendicular, the sealing agent is hardened to form a hollow cell. The liquid crystal MLC - 2 0 0 3 is injected into the hollow cell by a vacuum injection method. (manufactured by Merck, Japan), the injection port is closed, and the twisted nematic liquid crystal cell is obtained. <Measurement of pretilt angle> Heating at 1 〇 5 t is produced by the method described in <Liquid cell fabrication> above. Twisted nematic liquid crystal After 5 minutes, the measurement of the pretilt angle and the measurement of the voltage maintenance rate were carried out. The pretilt angle was measured by the crystal rotation method. <Measurement of voltage holding ratio> The twisted nematic direction produced by the method described in the above <Liquid cell production> The liquid crystal cell was applied with a voltage of 60 μδ at a temperature of 90 ° C, and a voltage of 16.67 ms was measured to determine how much voltage can be maintained as a voltage maintenance ratio. Further, the voltage maintenance rate is measured using a voltage maintenance ratio. Device (manufactured by Toyo Corporation, VHR-1). <Evaluation of Accumulated Charge (RDC)> The twisted-to-43-201132745 column type liquid crystal cell produced by the method described in the above <Liquid Cell Production>, at 2 3 At a temperature of ° C, a DC voltage was applied from 〇V to 1.0 V at a 0.1 V interval, and the Flicker Amplitude level at each voltage was measured to prepare a correction line. Next, after grounding for 5 minutes, an AC voltage of 3.0 V and a DC voltage of 5.0 V were applied, and the scintillation amplitude level after 1 hour was measured, and the RDC was evaluated by comparison with a calibration line prepared in advance. The evaluation method of this RDC is called a scintillation reference method. (Example 1) 5.00 g (25 mmol) of CBDA was used as a tetracarboxylic dianhydride component, and 6.30 g (26 mmol) of DABPh was used as a diamine component, and reacted in NMP 45.18 g at room temperature for 16 hours to obtain 20% by mass. Poly-proline solution (PAA-1). 10.0 g of the polyamic acid solution (PAA-1) was diluted with NMP 13.3 g and BC l〇.〇g to obtain a liquid crystal alignment composed of a solution containing 6 mass% solid content, 64 mass% NMP, and 30 mass% BC. Treatment agent. (Example 2) 93.33 g of NMP was added to 40 g of the polyamic acid solution (PAA-1 concentration: 20% by mass) obtained in Example 1, and diluted, followed by the addition of 5.64 g of acetic anhydride and 2.33 g of pyridine, at 4 ( The TC was reacted for 3 hours to carry out hydrazine imidization. After the reaction solution was cooled to about room temperature, it was poured into methanol 500 ml, and the precipitated solid matter was recovered. Then, after washing the solid matter several times with methanol, Drying under reduced pressure at 10 ° C to obtain a white powder of polyimine (SPI-1). The number average molecular weight of the polyimine is 14,630, and the weight average molecular weight is -44-201132745 3 2,1 60 Further, '醯imination rate was 8 2 % ° 18.0 g of γ-BL was added to the obtained polyamidimide (SPI-1) 2.00 g, and stirred at 5 (TC for 2 hours). At the time, the polyimine was completely dissolved. Then, 8.0 g of γ-BL, 6.00 g of BC, and 6.00 g of DPM were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain a polyfluorene containing 5 mass··. A liquid crystal alignment treatment agent consisting of a solution of imine (SPI-1), 65 masses of 15 mass% 2DPM, and 15 mass% of BC. (Example 3) 5.00 g (25 mmol) of CBDA was used as Residual acid dioxime: l: component, 6,32 g (26 mmol) of DABPy as a diamine component, reacted in NMP 45_29g at room temperature for 16 hours to obtain 20% by mass of poly-proline solution (PAA-2) The polyamic acid solution (PAA-2) 10.〇g was diluted with NMP 13.3g and BC lO.Og to obtain a solution containing 6 mass% solid content, 64 mass% NMP and 30 mass% BC. Liquid crystal alignment treatment agent. (Example 4) 93.3 g of NMP was added to 40 g of the polyamic acid solution (PAA-2 concentration: 20% by mass) obtained in Example 3, and then diluted, followed by the addition of 5.77 g of acetic anhydride and pyridine. 2.39 g, the imidization was carried out by reacting for 3 hours at 40 ° C. After cooling the reaction solution to about room temperature, it was poured into 500 mL of methanol to recover the precipitated solid matter. Then, the solid matter was washed several times with methanol. Thereafter, it was dried under reduced pressure at 100 ° C to obtain a white powder of polyimine (SPI-2). The number average molecular weight of the polyethylenimine was -13,204' and the weight average molecular weight was 30,700. The sulfhydrylation rate was 87%. 18.0 g of γ-BL was added to the obtained polyamidimide (SPI-2) 2.00 g, and stirred at 50 °C. 20 hours. At the end of the stirring, the polyimine was completely dissolved. Then, 8.0 g of γ-BL, 6.00 g of BC and 6.00 g of DPM were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain A liquid crystal alignment treatment agent comprising a solution of 5 mass% of polyimine (SPI-2), 65 mass% of γ-BL, 15 mass% of 2DPM, and 15 mass% of BC. (Example 5) 5.30 g (27 mmol) of CBDA was used as a tetracarboxylic dianhydride component, 2.00 g (8 mmol) of DABPh, 1.35 g (1 mmol) of 3-ABA and 2.65 g (8 mmol). C14DAB was reacted as a diamine component in NMP 45.25 g at room temperature for 16 hours to obtain 20 mass%. Poly-proline solution (PAA-3). The polyamino acid solution (PAA-3) was diluted 10.0 g with NMP 13.3 g and BC 10.0 g to obtain a content of 6 mass. /. A liquid crystal alignment treatment agent composed of a solid matter, a solution of 64% by mass of NMP and 30% by mass of BC. (Example 6) 93.3 3 g of NMP was added to 40 g of the polyamic acid solution (PAA-3 concentration: 20% by mass) obtained in Example 5, followed by the addition of acetic anhydride (5.97 g and pyridine 2.47 g'). The hydrazine imidization was carried out by reacting at 60 ° C for 3 hours. The reaction solution was allowed to cool to about room temperature, and then poured into methanol at 50,000 m to recover the solid matter of the precipitate -46-201132745. Then, after washing the solid matter with methanol several times, it was dried under reduced pressure to obtain a milky white powder of polyimine (SPI-3). The number average molecular weight of the polyimine was 14,785 ' The weight average molecular weight was 3,7 8 3 3. Further, the oxime imidization ratio was 88%. 18.0 g of γ-BL was added to the obtained polyimine (SPI-3) 2.00 g at 50 The mixture was stirred for 20 hours at ° C. At the end of the stirring, the polyimine was completely dissolved. Then, 8.0 g of γ-BL, 6.00 g of BC and 6.00 g of DPM were added to the solution, and the mixture was stirred at 50 ° C for 2 hours. 'A liquid crystal alignment treatment agent comprising a solution of 5 mass% polyimine (SPI-3), 65 mass% of 丫-8!^, 15 mass% of DPM, and 15 mass% of BC was obtained. 7) 5.27 g (27 mmol) of CBDA was used as the tetracarboxylic dianhydride component, 2.00 g (8 mmol) of DABPy, 1.34 g (ll mmol) of 3-ABA and 2.63 g (8 mmol) of C14DAB as the diamine component in NMP. In 44.96 g, the reaction was carried out at room temperature for 16 hours to obtain 20% by mass of a polyaminic acid solution (PAA-4). The polyaminic acid solution (PAA-4) was diluted with NMP 13.3 g and BClO.Og. .Og, obtained by A liquid crystal alignment treatment agent having a composition of 6 mass% solid content '64 mass% NMP and 30 mass% BC. (Example 8) 93.3 3 g of NMP was added to the polyamine solution obtained in Example 7 ( PAA-4 concentration: 20% by mass) was diluted in 40 g, and then acetic anhydride-47-201132745 5.97 g and pyridine 2.47 g were added, and the reaction was carried out at 60 ° C for 3 hours to carry out hydrazine imidization. The reaction solution was cooled to room temperature. Thereafter, the mixture was poured into methanol of 500 ml, and the precipitated solid matter was recovered. Then, the solid matter was washed with methanol several times, and then dried under reduced pressure at 10 ° C to obtain polyimine (SPI-4). Milky white powder. The number average molecular weight of the polyimine is 15,5 94, the weight average molecular weight is 4 2, 3 2 0 ' and the imidization ratio is 87%. Adding 18.0 g of γ-BL In the obtained polyimine (SPI-4) 2.00 g, the mixture was stirred at 50 ° C for 20 hours. At the end of the kneading, the polyimine was completely dissolved. Then, 8.0 g of γ-BL was added to the solution. 6.00 g of BC and 6.00 g of DPM were stirred at 50 ° C for 20 hours to obtain γ-BL, 15 mass by mass of yttrium imine (SPI-4) containing 5% by mass. The liquid crystal composition of DPM and 15 mass% of the BC solution alignment treating agent. (Example 9) 5.57 g (29 mmol) of CBDA was used as a component of tetradecanoic acid, 2 to 38 g (9 mmol) of DABTMPz, 1.4 2 g (1 2 mm ο 1 ) of 3-ABA and 2.79 g (9 mmoI). C 1 4DAB was reacted as a diamine component in NΜP 46.7 g at room temperature for 16 hours to obtain a polyamine acid solution (PAA-5) having a concentration of 20% by mass. The polyamic acid solution (PAA-5) 10.Og was diluted with NMP 13.3g and BC 10.〇g, and obtained by containing 6% by mass of polyaminic acid (PAA-5), 64% by mass of NMP, and 30% by mass. Liquid crystal alignment treatment agent of BC solution composition - 48 - 201132745 (Example 1 〇) 93.3 g of NMP was added to the polyacrylic acid (PAA-5 ) solution obtained in the same manner as in Example 9 (PAA-5 concentration 20 mass) %) was diluted in 40.0 g, and 6.06 g of acetic anhydride and 2·5 3 g of pyridine were added, and the reaction was carried out for 6 hours at TC for 3 hours. After cooling the reaction solution to about room temperature, 500 mL of methanol was poured. The precipitated solid matter was recovered, and the solid matter was washed twice with methanol, and then dried under reduced pressure at 100 ° C to obtain a white tan powder of polyimine (SPI-5). The number average molecular weight was 14,222, and the weight average molecular weight was 33,154. Further, the oxime imidization ratio was 88%. 18.0 g of γ-BL was added to the obtained polyimine (SPI-5) 2.00 g, Stir at 50 ° C for 20 hours. At the end of the stirring, the polyimine was completely dissolved. Then, 8.00 g of γ-BL, 6.00 g of BC and 6.00 g of DPM were added to the solution, at 5 After stirring at 0 ° C for 20 hours, it was obtained by a solution containing 5% by mass of polyimine (SPI-5), 65 mass% of γ-BL, 15 mass%/〇 of DPM, and 15 mass% of BC. Liquid crystal alignment treatment agent (Comparative Example 1) 12.5 g (64 mmol) of CBDA was used as a tetracarboxylic dianhydride component, 5.56 g (46 mmol) of 3 - ABA and 6 · 2 5 g (20 mm ο 1 ) of C14DAB. As a diamine component, a reaction of 'reaction at room temperature for 16 hours' in NMP 97.20g yielded 20 masses. /〇 Polylysine solution (PAA-6) ° Diluted the polyamine with NMP 13.3g and BC lO.Og 10.0 g of an acid solution (PAA-6), a liquid crystal alignment treatment agent consisting of a solution containing 6 mass% of solids, 64 mass% of NMP, and 30 mass% of BC was obtained. -49 - 201132745 (Comparative Example 2) 1 16.67 g of NMP was added to 50 g of the polyamic acid solution (PAA-6) obtained in Comparative Example 1, and diluted, and 7.39 g of acetic anhydride and 3.15 g of pyridine were added, and the reaction was carried out at 70 ° C for 3 hours to carry out hydrazine imidization, but In the reaction, gelatinization was carried out. Further, 116.67 g of NMP was added to 50 g of polylysine solution (PAA-6) to be diluted, and 7.39 g of acetic anhydride and 3.15 g of pyridine were added to iodide. Temperature of 50 ° C. After the reaction solution was cooled to about room temperature, it was poured into 600 ml of methanol to recover a precipitated solid. Subsequently, the solid matter was washed with methanol several times, and then dried under reduced pressure at 10 ° C to obtain a white powder of polyethylenimine (SPI-6). The polyimine had a number average molecular weight of 16,338 and a weight average molecular weight of 399,86. The yield of hydrazine was 80%. 9 g of γ-BL was added to polyimine (SPI-6), 〇〇g, and stirred at 50 ° C for 20 hours. At the end of the agitation, the polyimine was completely dissolved. Next, 4.0 g of γ-BL, 3.0 g of BC, and 3.0 g of DPM were added to the solution, and the mixture was stirred at 50 t for 20 hours to obtain γ-BL, which was contained in an amount of 5% by mass, and 5% by mass. A liquid crystal alignment treatment agent comprising a solution of 5 mass% DP Μ and 15 mass% BC. (Comparative Example 3) 5.76 g (29 mmol) of CBDA was used as a tetracarboxylic dianhydride component, 2.31 g (9 mmol) of RefDA, 1.46 g (12 mmol) of 3_ABA, and 2.88 g (9 mmol) of C14DAB as a diamine component. In NMP 56.84g -50-201132745, it was reacted at room temperature for 16 hours to obtain a 20% by mass poly-proline solution (PAA-7). The polyamic acid solution (PAA-7) 1 O.Og was diluted with NMP 13.3g and BC lO.Og to obtain a liquid crystal alignment composed of a solution containing 6 mass% solids, 64 mass% NMP, and 30 mass% BC. Treatment agent. (Comparative Example 4) 1 1 6 · 6 7 g of Ν Μ P was added to 50 g of the polylysine solution (PAA-7) obtained in Comparative Example 3 to dilute it, and the addition of Q acetic anhydride 7.39 g and pyridine was added. 3.06 g was reacted at 70 ° C for 3 hours to carry out oxime imidization. After the reaction solution was cooled to about room temperature, it was poured into 600 mL of methanol to recover a precipitated solid. Next, the solid matter was washed with methanol several times, and then dried under reduced pressure to obtain a thin brown powder of polyimine (SPI-7). The number average molecular weight of the polyimine was 18,668, and the weight was 18. The average molecular weight was 41, 256. The oxime imidization ratio was 89%. 9 g of γ-BL was added to polyimine (SPI-7) l.〇〇g in '5 at TC for 20 hours. At the end of stirring At that time, the polyimine was completely dissolved. Then, 4.0 g of γ-BL, 3.0 g of BC, and 3.0 g of DPM were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain a phthalocyanine containing 5% by mass. A liquid crystal alignment treatment agent comprising an amine, a 65 mass% γ-BL, a 15 mass% DP Μ, and a 15 mass% BC solution. [Industrial Applicability] By the liquid crystal alignment treatment agent of the present invention, It is possible to obtain a liquid crystal alignment film which is strong in peeling or reduction, has a high voltage holding ratio, and is difficult to cause initial charge accumulation even when a direct current voltage is applied, and is obtained by using the liquid crystal alignment treatment agent of the present invention. The liquid crystal display element can be a highly reliable liquid crystal display device suitable for TN liquid Display elements using various modes, such as a crystal display element, an STN liquid crystal display element, a TFT liquid crystal display element, a VA liquid crystal display element, an IPS liquid crystal display element, an OC liquid crystal display element, etc. m 1] Polylysine solution or polyimine oxime Amination rate [%] dianhydride component (mmol) diamine component (mmol) solid component (%) Example 1 PAA-1 CBDA (25) DABPh (26) 6.0 Example 2 SPI-1 82 CBDA (25) DABPh(26) 5.0 Example 3 PAA-2 - CBDA(25) DABPy(26) 6.0 Example 4 SPI-2 87 CBDA(25) DABP Fire 26) 5.0 Example 5 PAA-3 - CBDA(27) 3- ABA(ll), DABPh(8), C14DAB(8) 6.0 Example 6 SPI-3 88 CBDA(27) 3-ABA(ll), DABPh(8), C14DAB(8) 5.0 Example 7 PAA-4 - CBDA(27) 3-ABA(ll), DABPy(8), C14DAB(8) 6.0 Example 8 SPI-4 87 CBDA(27) 3-ABA(ll), DABPy(8), C14DAB(8) 5.0 Implementation Example 9 PAA-5 - CBDA(29) 3-ABA(12), DABTMPz(9) C14DAB(9) 6.0 Example 10 SPI-5 88 CBDA(29) 3-ABA(12), DABTMPz(9) C14DAB( 9) 5.0 Comparative Example 1 PAA-6 - CBDA(64) 3-ABA(46), C14DAB(20) 6.0 Comparative Example 2 SPI-6 80 CBDA(64) 3-ABA(46), C14DAB(20) 5.0 Comparison Example 3 PAA-7 - CBDA ( 29) 3-ABA(12), RefDA(9), C14DAB(9) 6.0 Comparative Example 4 SPI-7 89 CBDA(29) 3-ABA(12), RefDA (9), C14DAB(9) 5.0 -52- 201132745 [Table 2] Frictional resistance inclination angle [. Voltage maintenance rate [%] 90° 〇 RDCm Example 1 〇 0.7 90 0.24 Example 2 〇 0.8 92 0.20 Example 3 〇 1.0 92 0.23 Example 4 〇 1.2 93 0.17 Example 5 〇 6.1 92 0.25 Example 6 〇 3.1 94 0.21 Example 7 〇5.1 93 0.20 Example 8 〇 3.4 95 0.16 Example 9 〇 5.7 93 0.21 Example 10 〇 3.7 95 0.15 Comparative Example 1 Δ 4.5 87 0.50 Comparative Example 2 X 3.1 92 0.45 Comparative Example 3 Δ 4.7 90 0.30 Comparative Example 4 Δ 3.3 92 0.25 In addition, the entire contents of the specification, application scope and abstract of Japanese Patent Application No. 2000 9-2 8 3 3 3 0, filed on December 14, 2009, are incorporated herein by reference. As a disclosure of the present specification. -53-
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009283330 | 2009-12-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201132745A true TW201132745A (en) | 2011-10-01 |
TWI502054B TWI502054B (en) | 2015-10-01 |
Family
ID=44167298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW099143744A TWI502054B (en) | 2009-12-14 | 2010-12-14 | A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5751171B2 (en) |
KR (1) | KR101742838B1 (en) |
CN (1) | CN102754020B (en) |
TW (1) | TWI502054B (en) |
WO (1) | WO2011074546A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI791614B (en) * | 2017-09-13 | 2023-02-11 | 日商日產化學股份有限公司 | Diamine, polymer, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5776908B2 (en) * | 2010-06-30 | 2015-09-09 | 日産化学工業株式会社 | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, and method for manufacturing liquid crystal display element |
JP6153512B2 (en) * | 2012-03-16 | 2017-06-28 | 株式会社壮驥 | Composition for forming liquid crystal alignment film and liquid crystal display element |
KR102710871B1 (en) * | 2015-10-14 | 2024-09-26 | 닛산 가가쿠 가부시키가이샤 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
JP7027890B2 (en) * | 2015-12-25 | 2022-03-02 | 日産化学株式会社 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
TWI687457B (en) * | 2016-08-24 | 2020-03-11 | 奇美實業股份有限公司 | Liquid crystal alignment agent and use thereof |
KR102537443B1 (en) | 2018-04-03 | 2023-05-30 | 삼성디스플레이 주식회사 | Liquid crystal display apparatus |
CN112457867B (en) * | 2020-12-15 | 2021-08-03 | 深圳清荷科技有限公司 | Liquid crystal film material, liquid crystal aligning agent, liquid crystal aligning film and preparation method thereof, and liquid crystal display element |
CN115490858B (en) * | 2022-10-08 | 2023-06-23 | 潍坊科技学院 | Dark brown high-temperature-resistant polyimide containing hetero pyrene structure and synthesis method thereof |
CN118290734B (en) * | 2024-06-06 | 2024-08-16 | 山东齐氟新材料有限公司 | Optically-controlled oriented liquid crystal orientation film containing hetero-pyrene structure, and preparation method and application thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6303742B1 (en) * | 1998-04-01 | 2001-10-16 | Kanekafuchi Kagaku Kogyo Kabushiki Kaisha | Polyimide compositions |
JP4258690B2 (en) * | 1999-05-26 | 2009-04-30 | 独立行政法人理化学研究所 | Photosensitive resin composition |
JP4635162B2 (en) * | 2000-04-27 | 2011-02-16 | 独立行政法人理化学研究所 | Method for producing aromatic diamine and aromatic diamine compound |
JP4168442B2 (en) | 2002-07-29 | 2008-10-22 | Jsr株式会社 | Diamine compound, polyamic acid, imidized polymer, liquid crystal aligning agent, and liquid crystal display element |
US7498068B2 (en) * | 2004-04-28 | 2009-03-03 | Nissan Chemical Industries, Ltd. | Liquid-crystal aligning agent, liquid-crystal alignment film comprising the same, and liquid-crystal element |
CN101633621A (en) * | 2004-04-28 | 2010-01-27 | 日产化学工业株式会社 | Liquid crystal orientation agent, liquid crystal orientation film and liquid crystal display element using liquid crystal orientation agent |
JP5301834B2 (en) * | 2004-10-13 | 2013-09-25 | ロリク アーゲー | Photocrosslinkable material |
-
2010
- 2010-12-13 WO PCT/JP2010/072400 patent/WO2011074546A1/en active Application Filing
- 2010-12-13 JP JP2011546117A patent/JP5751171B2/en active Active
- 2010-12-13 CN CN201080063462.8A patent/CN102754020B/en active Active
- 2010-12-13 KR KR1020127015035A patent/KR101742838B1/en active IP Right Grant
- 2010-12-14 TW TW099143744A patent/TWI502054B/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI791614B (en) * | 2017-09-13 | 2023-02-11 | 日商日產化學股份有限公司 | Diamine, polymer, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
Also Published As
Publication number | Publication date |
---|---|
KR101742838B1 (en) | 2017-06-01 |
TWI502054B (en) | 2015-10-01 |
WO2011074546A1 (en) | 2011-06-23 |
JP5751171B2 (en) | 2015-07-22 |
CN102754020B (en) | 2016-03-02 |
CN102754020A (en) | 2012-10-24 |
KR20120103629A (en) | 2012-09-19 |
JPWO2011074546A1 (en) | 2013-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI502054B (en) | A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device | |
TWI429617B (en) | Diamine compounds, polyamic acid, polyimide and liquid crystal alignment treatment agent | |
TWI485181B (en) | A liquid crystal alignment agent and a liquid crystal display device using the same, and novel diamine | |
JP4840137B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element using the same | |
TWI441801B (en) | Diamine compounds, polyamic acid, polyimide and liquid crystal alignment treatment agent | |
JP6060899B2 (en) | Polyimide precursor modified with dicarboxylic acid anhydride, imidized polyimide and liquid crystal aligning agent using the same | |
JP5660160B2 (en) | Diamine compound | |
TWI607265B (en) | Liquid crystal alignment agent containing a crosslinkable compound having a photoreactive group | |
TW201118062A (en) | Diamine compound, polyamic acid, polyimide, and liquid crystal aligning agent | |
TW201241046A (en) | Coating solution for forming polyimide film, liquid crystal alignment agent, polyimide film, liquid crystal alignment film, and liquid crystal display element | |
JP2012012493A (en) | Liquid crystal aligning agent and liquid crystal display element using the same | |
TW201211108A (en) | Liquid crystal aligning agent, liquid crystal alignment film produced using same, and liquid crystal display element | |
JP6183616B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TW201120099A (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display device, polyamic acid and compound | |
TWI670330B (en) | Liquid crystal aligning agent composition, method of producing liquid crystal alignment film and liquid crystal alignment film using the same, and liquid crystal display device using the same | |
TWI461462B (en) | A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device | |
TWI798503B (en) | Liquid crystal alignment composition, method of preparing liquid crystal alignment film, and liquid crystal alignment film, liquid crystal display using the same | |
TW201922926A (en) | Liquid crystal alignment agent composition, method of producing liquid crystal alignment film using the same, liquid crystal alignment film and liquid crystal display device using the same | |
US11345856B2 (en) | Liquid crystal aligning agent composition, method for producing liquid crystal alignment film using same, and liquid crystal alignment film using same | |
JP2023007402A (en) | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, polymer, and diamine | |
KR20200059040A (en) | Liquid crystal alignment composition, method of preparing liquid crystal alignment film, and liquid crystal alignment film, liquid crystal display using the same |